General Information of Drug (ID: DM0FB1J)

Drug Name
Sertraline Drug Info
Synonyms
Lustral; SRE; Sertralina; Sertralinum; Sertralina [Spanish]; Sertraline [Zoloft]; Sertralinum [Latin]; CP 51974; Cp 51974; Apo-Sertraline; Lustral (TN); Sertraline (INN); Sertraline (Zoloft); Sertraline [INN:BAN]; Zoloft (TN); (+)-Sertraline; (1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalen-1-amine; (1S-cis)-1,2,3,4-Tetrahydro-4-(3,4-dichlorophenyl)-N-methyl-1-naphthalenamine; (1S-cis)-4-(3,4-Dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-naphthalenamine
Indication
Disease Entry ICD 11 Status REF
Coronary heart disease BA80.Z Approved [1]
Depression 6A70-6A7Z Approved [2]
Epilepsy 8A60-8A68 Approved [1]
Obsessive compulsive disorder 6B20 Approved [1]
Panic disorder 6B01 Approved [1]
Post-traumatic stress disorder 6B40 Approved [1]
Therapeutic Class
Antidepressants
Cross-matching ID
PubChem CID
68617
ChEBI ID
CHEBI:9123
CAS Number
CAS 79617-96-2
TTD Drug ID
DM0FB1J
VARIDT Drug ID
DR00440
INTEDE Drug ID
DR1477
ACDINA Drug ID
D00620

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
DTP
DME
DOT
Drug Status:
Approved Drug(s)
Clinical Trial Drug(s)
Patented Agent(s)
Preclinical Drug(s)
Investigative Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [18]
Amitriptyline DMK7F9S Depression 6A70-6A7Z Approved [19]
Fluoxetine DM3PD2C Bipolar depression Approved [20]
Vortioxetine DM6F1PU Major depressive disorder 6A70.3 Approved [21]
Cocaine DMSOX7I Anaesthesia 9A78.6 Approved [22]
Bupropion DM5PCS7 Depression 6A70-6A7Z Approved [23]
Citalopram DM2G9AE Acute coronary syndrome BA41 Approved [20]
Nortriptyline DM4KDYJ Depression 6A70-6A7Z Approved [20]
Trazodone DMK1GBJ Depression 6A70-6A7Z Approved [20]
Paroxetine DM5PVQE Anxiety disorder 6B00-6B0Z Approved [20]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Transported By P-glycoprotein 1 (ABCB1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Amoxicillin DMUYNEI Acute otitis media AB00 Approved [24]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [25]
Methotrexate DM2TEOL Anterior urethra cancer Approved [26]
Folic Acid DMEMBJC Colorectal carcinoma Approved [27]
Fluorouracil DMUM7HZ Adenocarcinoma 2D40 Approved [26]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [26]
Progesterone DMUY35B Amenorrhea GA20.0 Approved [28]
Tamoxifen DMLB0EZ Breast cancer 2C60-2C65 Approved [26]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [29]
Imatinib DM7RJXL Acute lymphoblastic leukaemia 2A85 Approved [30]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Metabolized By Cytochrome P450 3A4 (CYP3A4)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [31]
Progesterone DMUY35B Amenorrhea GA20.0 Approved [32]
Tamoxifen DMLB0EZ Breast cancer 2C60-2C65 Approved [33]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [34]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [35]
Imatinib DM7RJXL Acute lymphoblastic leukaemia 2A85 Approved [36]
Etoposide DMNH3PG Acute myelogenous leukaemia 2A41 Approved [37]
Zidovudine DM4KI7O Human immunodeficiency virus infection 1C62 Approved [38]
Prasterone DM67VKL Chronic obstructive pulmonary disease CA22 Approved [32]
Verapamil DMA7PEW Angina pectoris BA40 Approved [39]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Metabolized By Cytochrome P450 1A2 (CYP1A2)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fluorouracil DMUM7HZ Adenocarcinoma 2D40 Approved [40]
Dinoprostone DMTYOPD Medical abortion JA00.1Z Approved [41]
Tamoxifen DMLB0EZ Breast cancer 2C60-2C65 Approved [42]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [43]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [44]
Imatinib DM7RJXL Acute lymphoblastic leukaemia 2A85 Approved [45]
Etoposide DMNH3PG Acute myelogenous leukaemia 2A41 Approved [37]
Oxaliplatin DMQNWRD Adenocarcinoma 2D40 Approved [46]
Verapamil DMA7PEW Angina pectoris BA40 Approved [47]
Diclofenac DMPIHLS Chronic renal failure GB61.Z Approved [48]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Metabolized By Cytochrome P450 2D6 (CYP2D6)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [49]
Progesterone DMUY35B Amenorrhea GA20.0 Approved [50]
Tamoxifen DMLB0EZ Breast cancer 2C60-2C65 Approved [51]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [35]
Imatinib DM7RJXL Acute lymphoblastic leukaemia 2A85 Approved [39]
Quinine DMSWYF5 Malaria 1F40-1F45 Approved [52]
Propofol DMB4OLE Anaesthesia 9A78.6 Approved [53]
Dopamine DMPGUCF Acromegaly 5A60.0 Approved [54]
Nicotine DMWX5CO Lung cancer 2C25.0 Approved [55]
Propranolol DM79NTF Angina pectoris BA40 Approved [56]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [99]
Paliperidone DM7NPJS Psychotic disorder 6A20-6A25 Approved [100]
Dopamine DMPGUCF Acromegaly 5A60.0 Approved [101]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [102]
Oxatomide DM1F42Z Hay fever CA08.00 Approved [103]
Cinacalcet DMCX0K3 Hyperparathyroidism 5A51 Approved [104]
Capsaicin DMGMF6V Back pain ME84.Z Approved [105]
Pentamidine DMHZJCG African trypanosomiasis 1F51 Approved [106]
Quinidine DMLPICK N. A. N. A. Approved [107]
Buprenorphine DMPRI8G Opioid dependence 6C43.2Z Approved [108]
⏷ Show the Full List of 20 Drug(s)
Drug(s) Metabolized By Cytochrome P450 2E1 (CYP2E1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Folic Acid DMEMBJC Colorectal carcinoma Approved [57]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [58]
Tamoxifen DMLB0EZ Breast cancer 2C60-2C65 Approved [59]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [60]
Etoposide DMNH3PG Acute myelogenous leukaemia 2A41 Approved [61]
Oxaliplatin DMQNWRD Adenocarcinoma 2D40 Approved [46]
Verapamil DMA7PEW Angina pectoris BA40 Approved [62]
Estrone DM5T6US Acne vulgaris ED80 Approved [63]
Propofol DMB4OLE Anaesthesia 9A78.6 Approved [64]
Ethanol DMDRQZU Chronic pain MG30 Approved [65]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Metabolized By Cytochrome P450 2C9 (CYP2C9)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Progesterone DMUY35B Amenorrhea GA20.0 Approved [66]
Tamoxifen DMLB0EZ Breast cancer 2C60-2C65 Approved [67]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [68]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [62]
Imatinib DM7RJXL Acute lymphoblastic leukaemia 2A85 Approved [69]
Zidovudine DM4KI7O Human immunodeficiency virus infection 1C62 Approved [62]
Verapamil DMA7PEW Angina pectoris BA40 Approved [70]
Diclofenac DMPIHLS Chronic renal failure GB61.Z Approved [71]
Estrone DM5T6US Acne vulgaris ED80 Approved [72]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [73]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Metabolized By Cytochrome P450 2B6 (CYP2B6)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tamoxifen DMLB0EZ Breast cancer 2C60-2C65 Approved [74]
Verapamil DMA7PEW Angina pectoris BA40 Approved [62]
Diclofenac DMPIHLS Chronic renal failure GB61.Z Approved [75]
Estrone DM5T6US Acne vulgaris ED80 Approved [68]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [76]
Irinotecan DMP6SC2 Adenocarcinoma 2D40 Approved [77]
Propofol DMB4OLE Anaesthesia 9A78.6 Approved [78]
Nicotine DMWX5CO Lung cancer 2C25.0 Approved [79]
Phenytoin DMNOKBV Epilepsy 8A60-8A68 Approved [80]
Amitriptyline DMK7F9S Depression 6A70-6A7Z Approved [81]
Ritonavir DMU764S Human immunodeficiency virus infection 1C62 Approved [89]
Rifampicin DM5DSFZ Non-insulin dependent diabetes 5A11 Approved [90]
Thalidomide DM70BU5 Adult T-cell leukemia/lymphoma Approved [91]
Phenytoin DMNOKBV Epilepsy 8A60-8A68 Approved [92]
Clopidogrel DMOL54H Acute coronary syndrome BA41 Approved [93]
Artemisinin DMOY7W3 Malaria 1F40-1F45 Approved [94]
Malathion DMXZ84M Pediculus capitis infestation 1G00.0 Approved [95]
Phenobarbital DMXZOCG Cluster headache 8A81.0 Approved [96]
Permethrin DMZ0Q1G Pediculus capitis infestation 1G00.0 Approved [97]
Carbamazepine DMZOLBI Epilepsy 8A60-8A68 Approved [98]
⏷ Show the Full List of 20 Drug(s)
Drug(s) Metabolized By Mephenytoin 4-hydroxylase (CYP2C19)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Amoxicillin DMUYNEI Acute otitis media AB00 Approved [82]
Progesterone DMUY35B Amenorrhea GA20.0 Approved [66]
Tamoxifen DMLB0EZ Breast cancer 2C60-2C65 Approved [83]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [84]
Zidovudine DM4KI7O Human immunodeficiency virus infection 1C62 Approved [62]
Verapamil DMA7PEW Angina pectoris BA40 Approved [85]
Diclofenac DMPIHLS Chronic renal failure GB61.Z Approved [86]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [73]
Quinine DMSWYF5 Malaria 1F40-1F45 Approved [87]
Propofol DMB4OLE Anaesthesia 9A78.6 Approved [88]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Cytochrome P450 2C19 (CYP2C19)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [109]
Thioridazine DM35M8J Schizophrenia 6A20 Approved [110]
Voriconazole DMAOL2S Aspergillosis 1F20 Approved [111]
Chloramphenicol DMFXEWT Bacterial infection 1A00-1C4Z Approved [112]
Capsaicin DMGMF6V Back pain ME84.Z Approved [105]
Pentamidine DMHZJCG African trypanosomiasis 1F51 Approved [106]
Stiripentol DMMSDOY Dravet syndrome 8A61.11 Approved [113]
Quinine DMSWYF5 Malaria 1F40-1F45 Approved [106]
Desipramine DMT2FDC Attention deficit hyperactivity disorder 6A05.Z Approved [110]
Amitriptyline DMK7F9S Depression 6A70-6A7Z Approved [114]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Flupentixol DM0DJ9O Schizophrenia 6A20 Approved [115]
Crizotinib DM4F29C Non-small-cell lung cancer 2C25.Y Approved [116]
Lamotrigine DM8SXYG Bipolar disorder 6A60 Approved [117]
Cepharanthine DM9Y5JB N. A. N. A. Approved [118]
Itraconazole DMCR1MV Aspergillosis 1F20 Approved [119]
Clozapine DMFC71L Schizophrenia 6A20 Approved [120]
Midostaurin DMI6E0R Acute myeloid leukaemia 2A60 Approved [121]
Trifluoperazine DMKBYWI Anxiety Approved [122]
Olanzapine DMPFN6Y Bipolar depression Approved [120]
Levetiracetam DMTGDN8 Epilepsy 8A60-8A68 Approved [117]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Ofloxacin DM0VQN3 Acute gonococcal cervicitis Approved [12]
Methotrexate DM2TEOL Anterior urethra cancer Approved [123]
Thioridazine DM35M8J Schizophrenia 6A20 Approved [12]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [124]
Clarithromycin DM4M1SG Acute maxillary sinusitis Approved [12]
Chlorpromazine DMBGZI3 Acute intermittent hepatic porphyria 5C58.11 Approved [12]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [125]
Sulfamethoxazole DMB08GE Acute otitis media AB00 Approved [12]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [126]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [127]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Nuclear protein 1 (NUPR1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [128]
Ofloxacin DM0VQN3 Acute gonococcal cervicitis Approved [129]
Citalopram DM2G9AE Acute coronary syndrome BA41 Approved [130]
Imipramine DM2NUH3 Depression 6A70-6A7Z Approved [12]
Thioridazine DM35M8J Schizophrenia 6A20 Approved [12]
Quercetin DM3NC4M Obesity 5B81 Approved [131]
Fluoxetine DM3PD2C Bipolar depression Approved [12]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [132]
Erythromycin DM4K7GQ Acne vulgaris ED80 Approved [129]
Isoniazid DM5JVS3 Latent tuberculosis infection Approved [129]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [133]
Citalopram DM2G9AE Acute coronary syndrome BA41 Approved [130]
Imipramine DM2NUH3 Depression 6A70-6A7Z Approved [12]
Thioridazine DM35M8J Schizophrenia 6A20 Approved [12]
Rofecoxib DM3P5DA Osteoarthritis FA00-FA05 Approved [134]
Fluoxetine DM3PD2C Bipolar depression Approved [12]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [135]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [135]
Chlorpromazine DMBGZI3 Acute intermittent hepatic porphyria 5C58.11 Approved [12]
Aspirin DM672AH Acute coronary syndrome BA41 Approved [136]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Serine protease hepsin (HPN)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Selenium DM25CGV N. A. N. A. Approved [137]
Imipramine DM2NUH3 Depression 6A70-6A7Z Approved [12]
Thioridazine DM35M8J Schizophrenia 6A20 Approved [12]
Quercetin DM3NC4M Obesity 5B81 Approved [131]
Fluoxetine DM3PD2C Bipolar depression Approved [12]
Erythromycin DM4K7GQ Acne vulgaris ED80 Approved [129]
Chlorpromazine DMBGZI3 Acute intermittent hepatic porphyria 5C58.11 Approved [12]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [138]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [125]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [139]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [140]
Citalopram DM2G9AE Acute coronary syndrome BA41 Approved [130]
Imipramine DM2NUH3 Depression 6A70-6A7Z Approved [12]
Methotrexate DM2TEOL Anterior urethra cancer Approved [123]
Thioridazine DM35M8J Schizophrenia 6A20 Approved [12]
Quercetin DM3NC4M Obesity 5B81 Approved [131]
Fluoxetine DM3PD2C Bipolar depression Approved [12]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [141]
Erythromycin DM4K7GQ Acne vulgaris ED80 Approved [129]
Chlorpromazine DMBGZI3 Acute intermittent hepatic porphyria 5C58.11 Approved [12]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Asparagine synthetase (ASNS)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [142]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [143]
Imipramine DM2NUH3 Depression 6A70-6A7Z Approved [12]
Sulindac DM2QHZU Acute myelogenous leukaemia 2A41 Approved [144]
Methotrexate DM2TEOL Anterior urethra cancer Approved [145]
Thioridazine DM35M8J Schizophrenia 6A20 Approved [129]
Fluoxetine DM3PD2C Bipolar depression Approved [12]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [146]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [124]
Methylprednisolone DM4BDON Acute adrenal insufficiency Approved [145]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
2-deoxyglucose DMIAHVU Solid tumour/cancer 2A00-2F9Z Approved [147]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [148]
Citalopram DM2G9AE Acute coronary syndrome BA41 Approved [130]
Imipramine DM2NUH3 Depression 6A70-6A7Z Approved [12]
Methotrexate DM2TEOL Anterior urethra cancer Approved [149]
Thioridazine DM35M8J Schizophrenia 6A20 Approved [12]
Quercetin DM3NC4M Obesity 5B81 Approved [131]
Fluoxetine DM3PD2C Bipolar depression Approved [12]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [150]
Zidovudine DM4KI7O Human immunodeficiency virus infection 1C62 Approved [151]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Lanosterol synthase (LSS)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Clavulanate DM2FGRT Bacteremia 1A73 Approved [152]
Imipramine DM2NUH3 Depression 6A70-6A7Z Approved [12]
Thioridazine DM35M8J Schizophrenia 6A20 Approved [12]
Quercetin DM3NC4M Obesity 5B81 Approved [131]
Fluoxetine DM3PD2C Bipolar depression Approved [12]
obeticholic acid DM3Q1SM Primary biliary cholangitis DB96.1 Approved [153]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [154]
Erythromycin DM4K7GQ Acne vulgaris ED80 Approved [129]
Clarithromycin DM4M1SG Acute maxillary sinusitis Approved [12]
Chlorpromazine DMBGZI3 Acute intermittent hepatic porphyria 5C58.11 Approved [12]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Inhibin beta E chain (INHBE)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Citalopram DM2G9AE Acute coronary syndrome BA41 Approved [130]
Imipramine DM2NUH3 Depression 6A70-6A7Z Approved [12]
Thioridazine DM35M8J Schizophrenia 6A20 Approved [12]
Quercetin DM3NC4M Obesity 5B81 Approved [131]
Fluoxetine DM3PD2C Bipolar depression Approved [12]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [154]
Erythromycin DM4K7GQ Acne vulgaris ED80 Approved [129]
Clarithromycin DM4M1SG Acute maxillary sinusitis Approved [12]
Panobinostat DM58WKG Chronic graft versus host disease Approved [155]
Isoniazid DM5JVS3 Latent tuberculosis infection Approved [129]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Transgelin (TAGLN)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [156]
Citalopram DM2G9AE Acute coronary syndrome BA41 Approved [130]
Imipramine DM2NUH3 Depression 6A70-6A7Z Approved [12]
Methotrexate DM2TEOL Anterior urethra cancer Approved [157]
Thioridazine DM35M8J Schizophrenia 6A20 Approved [12]
Quercetin DM3NC4M Obesity 5B81 Approved [131]
Fluoxetine DM3PD2C Bipolar depression Approved [12]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [158]
Erythromycin DM4K7GQ Acne vulgaris ED80 Approved [130]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [159]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Acid ceramidase (ASAH1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Beta-carotene DM0RXBT Vitamin deficiency 5B55-5B71 Approved [160]
Ofloxacin DM0VQN3 Acute gonococcal cervicitis Approved [129]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [161]
Imipramine DM2NUH3 Depression 6A70-6A7Z Approved [12]
Thioridazine DM35M8J Schizophrenia 6A20 Approved [129]
Quercetin DM3NC4M Obesity 5B81 Approved [131]
Fluoxetine DM3PD2C Bipolar depression Approved [12]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [162]
Erythromycin DM4K7GQ Acne vulgaris ED80 Approved [129]
Clarithromycin DM4M1SG Acute maxillary sinusitis Approved [12]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Calcipotriol DM03CP7 Psoriasis EA90 Approved [163]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [164]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [165]
Clavulanate DM2FGRT Bacteremia 1A73 Approved [152]
Imipramine DM2NUH3 Depression 6A70-6A7Z Approved [12]
Thioridazine DM35M8J Schizophrenia 6A20 Approved [129]
Deoxycholic acid DM3GYAL Subcutaneous fat disorder EF02 Approved [166]
Quercetin DM3NC4M Obesity 5B81 Approved [131]
Fluoxetine DM3PD2C Bipolar depression Approved [12]
obeticholic acid DM3Q1SM Primary biliary cholangitis DB96.1 Approved [167]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Citalopram DM2G9AE Acute coronary syndrome BA41 Approved [130]
Imipramine DM2NUH3 Depression 6A70-6A7Z Approved [12]
Thioridazine DM35M8J Schizophrenia 6A20 Approved [129]
Fluoxetine DM3PD2C Bipolar depression Approved [129]
Chlorpromazine DMBGZI3 Acute intermittent hepatic porphyria 5C58.11 Approved [12]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [168]
Testosterone DM7HUNW Hot flushes GA30 Approved [169]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [169]
Haloperidol DM96SE0 Delirium Approved [129]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [170]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Imipramine DM2NUH3 Depression 6A70-6A7Z Approved [12]
Thioridazine DM35M8J Schizophrenia 6A20 Approved [12]
Fluoxetine DM3PD2C Bipolar depression Approved [12]
Erythromycin DM4K7GQ Acne vulgaris ED80 Approved [129]
Chlorpromazine DMBGZI3 Acute intermittent hepatic porphyria 5C58.11 Approved [12]
Haloperidol DM96SE0 Delirium Approved [129]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [125]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [139]
Clozapine DMFC71L Schizophrenia 6A20 Approved [12]
Pentamidine DMHZJCG African trypanosomiasis 1F51 Approved [12]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Protein DEPP1 (DEPP1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Ofloxacin DM0VQN3 Acute gonococcal cervicitis Approved [129]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [171]
Imipramine DM2NUH3 Depression 6A70-6A7Z Approved [12]
Thioridazine DM35M8J Schizophrenia 6A20 Approved [12]
Quercetin DM3NC4M Obesity 5B81 Approved [131]
Fluoxetine DM3PD2C Bipolar depression Approved [12]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [172]
Erythromycin DM4K7GQ Acne vulgaris ED80 Approved [129]
Isoniazid DM5JVS3 Latent tuberculosis infection Approved [129]
Chlorpromazine DMBGZI3 Acute intermittent hepatic porphyria 5C58.11 Approved [12]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Eicosapentaenoic acid/docosa-hexaenoic acid DMMUCG4 Hypertriglyceridemia 5C80.1 Approved [173]
Etoposide DMNH3PG Acute myelogenous leukaemia 2A41 Approved [174]
Gamolenic acid DMQN30Z Allergy 4A80-4A85 Approved [175]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [176]
Flupentixol DM0DJ9O Schizophrenia 6A20 Approved [177]
Ibandronate DM0QZBN Hypercalcaemia 5B91.0 Approved [178]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [164]
Fexofenadine DM17ONX Allergic rhinitis CA08.0 Approved [179]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [180]
Lumiracoxib DM1S4AG Chronic renal failure GB61.Z Approved [181]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Dexamethasone DMMWZET Acute adrenal insufficiency Approved [114]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [182]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [183]
Trametinib DM2JGQ3 Melanoma 2C30 Approved [184]
Sulindac DM2QHZU Acute myelogenous leukaemia 2A41 Approved [185]
Methotrexate DM2TEOL Anterior urethra cancer Approved [149]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [186]
Cladribine DM3JDRP Hairy cell leukaemia 2A82.2 Approved [187]
Quercetin DM3NC4M Obesity 5B81 Approved [188]
Rofecoxib DM3P5DA Osteoarthritis FA00-FA05 Approved [134]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Aromatase (CYP19A1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Letrozole DMH07Y3 Estrogen-receptor positive breast cancer Approved [189]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [190]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [164]
Citalopram DM2G9AE Acute coronary syndrome BA41 Approved [16]
Methotrexate DM2TEOL Anterior urethra cancer Approved [123]
FADROZOLE DM3C5GZ Breast cancer 2C60-2C65 Approved [191]
Bifonazole DM3KN7V Fungal infection 1F29-1F2F Approved [192]
Quercetin DM3NC4M Obesity 5B81 Approved [193]
Fluoxetine DM3PD2C Bipolar depression Approved [16]
obeticholic acid DM3Q1SM Primary biliary cholangitis DB96.1 Approved [153]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [131]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [124]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [125]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [194]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [195]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [196]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [197]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [198]
THAPSIGARGIN DMDMQIE N. A. N. A. Preclinical [199]
Glyphosate DM0AFY7 Malaria 1F40-1F45 Investigative [200]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [128]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [165]
Methotrexate DM2TEOL Anterior urethra cancer Approved [201]
Quercetin DM3NC4M Obesity 5B81 Approved [202]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [124]
Panobinostat DM58WKG Chronic graft versus host disease Approved [155]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [203]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [204]
Testosterone DM7HUNW Hot flushes GA30 Approved [169]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [169]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [205]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [206]
Sulindac DM2QHZU Acute myelogenous leukaemia 2A41 Approved [207]
Quercetin DM3NC4M Obesity 5B81 Approved [208]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [207]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [172]
Pyrazinamide DM4IF32 Meningeal tuberculosis Approved [209]
Glucosamine DM4ZLFD Osteoarthritis FA00-FA05 Approved [210]
Rifampicin DM5DSFZ Non-insulin dependent diabetes 5A11 Approved [207]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [211]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [142]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [212]
Methotrexate DM2TEOL Anterior urethra cancer Approved [213]
Quercetin DM3NC4M Obesity 5B81 Approved [131]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [146]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [214]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [168]
Thalidomide DM70BU5 Adult T-cell leukemia/lymphoma Approved [215]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [216]
Ibuprofen DM8VCBE Dysmenorrhea GA34.3 Approved [217]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [212]
Colchicine DM2POTE Acute gout flare FA25.0 Approved [218]
Methotrexate DM2TEOL Anterior urethra cancer Approved [219]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [124]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [204]
Testosterone DM7HUNW Hot flushes GA30 Approved [220]
Leflunomide DMR8ONJ Arthritis FA20 Approved [221]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [170]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [218]
Arsenic DMTL2Y1 N. A. N. A. Approved [222]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Methotrexate DM2TEOL Anterior urethra cancer Approved [201]
Quercetin DM3NC4M Obesity 5B81 Approved [131]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [124]
Aspirin DM672AH Acute coronary syndrome BA41 Approved [223]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [170]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [139]
Demecolcine DMCZQGK Solid tumour/cancer 2A00-2F9Z Approved [224]
Bortezomib DMNO38U Leukemia Approved [225]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [195]
Diclofenac DMPIHLS Chronic renal failure GB61.Z Approved [226]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
BIBW 2992 DMTKD7Q Non-small-cell lung cancer 2C25.Y Approved [227]
Gefitinib DM15F0X Colon adenocarcinoma Approved [228]
Erlotinib DMCMBHA Adrenal gland neoplasm Approved [229]
Lapatinib DM3BH1Y Breast cancer 2C60-2C65 Approved [230]
Gemcitabine DMSE3I7 Anterior urethra cancer Approved [231]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [232]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [233]
Selenium DM25CGV N. A. N. A. Approved [234]
Deoxycholic acid DM3GYAL Subcutaneous fat disorder EF02 Approved [235]
Quercetin DM3NC4M Obesity 5B81 Approved [236]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Protein c-Fos (FOS)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [237]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [238]
Verapamil DMA7PEW Angina pectoris BA40 Approved [239]
Acebutolol DM0TI4U Hypertension BA00-BA04 Approved [239]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [240]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [241]
Methotrexate DM2TEOL Anterior urethra cancer Approved [242]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [243]
Quercetin DM3NC4M Obesity 5B81 Approved [244]
Fluoxetine DM3PD2C Bipolar depression Approved [245]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [246]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [240]
Gefitinib DM15F0X Colon adenocarcinoma Approved [247]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [248]
Selenium DM25CGV N. A. N. A. Approved [249]
Ribavirin DMEYLH9 Hepatitis C virus infection 1E51.1 Approved [250]
Trametinib DM2JGQ3 Melanoma 2C30 Approved [251]
Sulindac DM2QHZU Acute myelogenous leukaemia 2A41 Approved [252]
Methotrexate DM2TEOL Anterior urethra cancer Approved [123]
Dactinomycin DM2YGNW Adult kidney Wilms tumor Approved [253]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Tumor necrosis factor (TNF)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Indomethacin DMSC4A7 Bursitis Approved [254]
Amphotericin B DMTAJQE Acne vulgaris ED80 Approved [255]
Fructose DM43AN2 Vomiting MD90 Approved [114]
Ketoprofen DMRKXPT Bursitis Approved [114]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [256]
Baclofen DM0QV1J Multiple sclerosis 8A40 Approved [257]
Gefitinib DM15F0X Colon adenocarcinoma Approved [258]
Ganciclovir DM1MBYQ Cytomegalovirus infection 1D82 Approved [259]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [133]
Nitric Oxide DM1RBYG Hypertension BA00-BA04 Approved [260]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [261]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [139]
Arsenic DMTL2Y1 N. A. N. A. Approved [222]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [262]
Urethane DM7NSI0 N. A. N. A. Phase 4 [263]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [197]
⏷ Show the Full List of 6 Drug(s)
Drug(s) Affected By Albumin (ALB)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [196]
Sulfamethoxazole DMB08GE Acute otitis media AB00 Approved [114]
Tolbutamide DM02AWV Advanced cancer 2A00-2F9Z Approved [264]
Diazepam DM08E9O Alcohol withdrawal Approved [265]
Methimazole DM25FL8 Hyperthyroidism 5A02 Approved [266]
Imipramine DM2NUH3 Depression 6A70-6A7Z Approved [267]
Colchicine DM2POTE Acute gout flare FA25.0 Approved [268]
Methotrexate DM2TEOL Anterior urethra cancer Approved [269]
Quercetin DM3NC4M Obesity 5B81 Approved [270]
obeticholic acid DM3Q1SM Primary biliary cholangitis DB96.1 Approved [153]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Platelet basic protein (PPBP)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Verapamil DMA7PEW Angina pectoris BA40 Approved [271]
Nortriptyline DM4KDYJ Depression 6A70-6A7Z Approved [272]
Paroxetine DM5PVQE Anxiety disorder 6B00-6B0Z Approved [272]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [273]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [142]
Amlodipine DMBDAZV Angina pectoris BA40 Approved [274]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [139]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [275]
Cocaine DMSOX7I Anaesthesia 9A78.6 Approved [276]
Arsenic DMTL2Y1 N. A. N. A. Approved [277]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Platelet factor 4 (PF4)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Verapamil DMA7PEW Angina pectoris BA40 Approved [271]
Methotrexate DM2TEOL Anterior urethra cancer Approved [123]
Fructose DM43AN2 Vomiting MD90 Approved [278]
Nortriptyline DM4KDYJ Depression 6A70-6A7Z Approved [272]
Paroxetine DM5PVQE Anxiety disorder 6B00-6B0Z Approved [272]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [279]
Cocaine DMSOX7I Anaesthesia 9A78.6 Approved [276]
Arsenic DMTL2Y1 N. A. N. A. Approved [280]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [281]
Ardeparin DMYRX8B Deep vein thrombosis BD71 Approved [282]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [143]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [283]
Quercetin DM3NC4M Obesity 5B81 Approved [131]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [284]
Penicillamine DM40EF6 Cystinuria 5C60.2 Approved [285]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [286]
Pyrazinamide DM4IF32 Meningeal tuberculosis Approved [209]
Zidovudine DM4KI7O Human immunodeficiency virus infection 1C62 Approved [287]
Glucosamine DM4ZLFD Osteoarthritis FA00-FA05 Approved [288]
Bupropion DM5PCS7 Depression 6A70-6A7Z Approved [289]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Transcription factor Jun (JUN)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Mitoxantrone DMM39BF Acute myelogenous leukaemia 2A41 Approved [290]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [291]
Fructose DM43AN2 Vomiting MD90 Approved [114]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [292]
Mechlorethamine DM0CVXA Chronic myelogenous leukaemia 2A20.0 Approved [293]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [294]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [295]
Colchicine DM2POTE Acute gout flare FA25.0 Approved [296]
Methotrexate DM2TEOL Anterior urethra cancer Approved [297]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [298]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [299]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [300]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [301]
Panobinostat DM58WKG Chronic graft versus host disease Approved [155]
Paroxetine DM5PVQE Anxiety disorder 6B00-6B0Z Approved [302]
Testosterone DM7HUNW Hot flushes GA30 Approved [220]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [138]
Clodronate DM9Y6X7 Hypercalcaemia 5B91.0 Approved [217]
Cidofovir DMA13GD Cytomegalovirus infection 1D82 Approved [217]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [217]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
obeticholic acid DM3Q1SM Primary biliary cholangitis DB96.1 Approved [153]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [146]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [303]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [214]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [304]
Ergotidine DM78IME Osteoarthritis FA00-FA05 Approved [305]
Testosterone DM7HUNW Hot flushes GA30 Approved [169]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [306]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [125]
Atorvastatin DMF28YC Acute coronary syndrome BA41 Approved [307]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Carbamazepine DMZOLBI Epilepsy 8A60-8A68 Approved [308]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [142]
Gefitinib DM15F0X Colon adenocarcinoma Approved [309]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [310]
Selenium DM25CGV N. A. N. A. Approved [137]
Etretinate DM2CZFA Keratosis ED56 Approved [311]
Methotrexate DM2TEOL Anterior urethra cancer Approved [123]
Quercetin DM3NC4M Obesity 5B81 Approved [131]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [312]
Penicillamine DM40EF6 Cystinuria 5C60.2 Approved [285]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Sevoflurane DMC9O43 Anaesthesia 9A78.6 Approved [313]
Docetaxel DMDI269 Advanced cancer 2A00-2F9Z Approved [314]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [315]
Gemcitabine DMSE3I7 Anterior urethra cancer Approved [316]
Etoposide DMNH3PG Acute myelogenous leukaemia 2A41 Approved [114]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [128]
Verapamil DMA7PEW Angina pectoris BA40 Approved [317]
Mechlorethamine DM0CVXA Chronic myelogenous leukaemia 2A20.0 Approved [318]
Beta-carotene DM0RXBT Vitamin deficiency 5B55-5B71 Approved [319]
Flucytosine DM13VTW Cryptococcal meningitis Approved [320]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [321]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [143]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [233]
Etretinate DM2CZFA Keratosis ED56 Approved [311]
Quercetin DM3NC4M Obesity 5B81 Approved [322]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [323]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [324]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [325]
Ibuprofen DM8VCBE Dysmenorrhea GA34.3 Approved [326]
Leflunomide DMR8ONJ Arthritis FA20 Approved [221]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [295]
Methotrexate DM2TEOL Anterior urethra cancer Approved [149]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [327]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [328]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [125]
Sevoflurane DMC9O43 Anaesthesia 9A78.6 Approved [329]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [139]
Diethylstilbestrol DMN3UXQ Gonorrheal vaginitis GA02 Approved [330]
Bortezomib DMNO38U Leukemia Approved [225]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [195]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By P-selectin (SELP)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [124]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [331]
Aspirin DM672AH Acute coronary syndrome BA41 Approved [332]
Amlodipine DMBDAZV Angina pectoris BA40 Approved [274]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [139]
Asasantin DMCZIHT Cerebrovascular ischaemia 8B1Z Approved [333]
Cimetidine DMH61ZB Acid-reflux disorder DA22 Approved [334]
Rosiglitazone DMILWZR Chronic kidney disease GB61 Approved [335]
Cocaine DMSOX7I Anaesthesia 9A78.6 Approved [276]
Ardeparin DMYRX8B Deep vein thrombosis BD71 Approved [336]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Gefitinib DM15F0X Colon adenocarcinoma Approved [258]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [124]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [337]
Aspirin DM672AH Acute coronary syndrome BA41 Approved [136]
Thalidomide DM70BU5 Adult T-cell leukemia/lymphoma Approved [338]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [339]
Asasantin DMCZIHT Cerebrovascular ischaemia 8B1Z Approved [333]
Folic Acid DMEMBJC Colorectal carcinoma Approved [340]
Rosiglitazone DMILWZR Chronic kidney disease GB61 Approved [341]
Vitamin B3 DMQVRZH Chronic renal failure GB61.Z Approved [342]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By E-selectin (SELE)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [343]
Methotrexate DM2TEOL Anterior urethra cancer Approved [344]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [345]
Deoxycholic acid DM3GYAL Subcutaneous fat disorder EF02 Approved [346]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [347]
Erythromycin DM4K7GQ Acne vulgaris ED80 Approved [348]
Tibolone DM78XFG Anabolic metabolism 5C50-5C8Z Approved [349]
Atorvastatin DMF28YC Acute coronary syndrome BA41 Approved [350]
Sulfasalazine DMICA9H Irritable bowel syndrome DD91.0 Approved [351]
Rosiglitazone DMILWZR Chronic kidney disease GB61 Approved [352]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Stathmin (STMN1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [143]
Etretinate DM2CZFA Keratosis ED56 Approved [311]
Quercetin DM3NC4M Obesity 5B81 Approved [353]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [146]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [323]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [354]
Testosterone DM7HUNW Hot flushes GA30 Approved [169]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [169]
Leflunomide DMR8ONJ Arthritis FA20 Approved [221]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [125]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [142]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [310]
Quercetin DM3NC4M Obesity 5B81 Approved [355]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [146]
Penicillamine DM40EF6 Cystinuria 5C60.2 Approved [285]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [172]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [356]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [325]
Leflunomide DMR8ONJ Arthritis FA20 Approved [221]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [125]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Mechlorethamine DM0CVXA Chronic myelogenous leukaemia 2A20.0 Approved [293]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [241]
Sulindac DM2QHZU Acute myelogenous leukaemia 2A41 Approved [144]
Quercetin DM3NC4M Obesity 5B81 Approved [131]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [357]
Acetic Acid, Glacial DM4SJ5Y infection in the ear canal AA0Y Approved [358]
Nefazodone DM4ZS8M Major depressive disorder 6A70.3 Approved [359]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [248]
Aspirin DM672AH Acute coronary syndrome BA41 Approved [360]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [361]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Bepridil DM0RKS4 Chronic/stable angina BA40.1 Approved [362]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [241]
Selenium DM25CGV N. A. N. A. Approved [137]
Sulindac DM2QHZU Acute myelogenous leukaemia 2A41 Approved [144]
Pyrazinamide DM4IF32 Meningeal tuberculosis Approved [209]
Glucosamine DM4ZLFD Osteoarthritis FA00-FA05 Approved [210]
Nefazodone DM4ZS8M Major depressive disorder 6A70.3 Approved [359]
Rifampicin DM5DSFZ Non-insulin dependent diabetes 5A11 Approved [363]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [327]
Aspirin DM672AH Acute coronary syndrome BA41 Approved [223]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Dexamethasone DMMWZET Acute adrenal insufficiency Approved [364]
Aspirin DM672AH Acute coronary syndrome BA41 Approved [360]
Gefitinib DM15F0X Colon adenocarcinoma Approved [365]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [241]
Sulindac DM2QHZU Acute myelogenous leukaemia 2A41 Approved [366]
Methotrexate DM2TEOL Anterior urethra cancer Approved [367]
Dactinomycin DM2YGNW Adult kidney Wilms tumor Approved [253]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [368]
Quercetin DM3NC4M Obesity 5B81 Approved [369]
obeticholic acid DM3Q1SM Primary biliary cholangitis DB96.1 Approved [153]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Dexamethasone DMMWZET Acute adrenal insufficiency Approved [370]
Gefitinib DM15F0X Colon adenocarcinoma Approved [371]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [372]
Trametinib DM2JGQ3 Melanoma 2C30 Approved [251]
Quercetin DM3NC4M Obesity 5B81 Approved [373]
Romiplostim DM3U7SZ Thrombocytopenia 3B64 Approved [374]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [375]
Glucosamine DM4ZLFD Osteoarthritis FA00-FA05 Approved [376]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [377]
Testosterone DM7HUNW Hot flushes GA30 Approved [378]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [142]
Gefitinib DM15F0X Colon adenocarcinoma Approved [365]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [379]
Sulindac DM2QHZU Acute myelogenous leukaemia 2A41 Approved [144]
Methotrexate DM2TEOL Anterior urethra cancer Approved [380]
Dactinomycin DM2YGNW Adult kidney Wilms tumor Approved [381]
Quercetin DM3NC4M Obesity 5B81 Approved [382]
Furazolidone DM3P6V7 Diarrhea ME05.1 Approved [383]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [384]
Penicillamine DM40EF6 Cystinuria 5C60.2 Approved [285]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [385]
Progesterone DMUY35B Amenorrhea GA20.0 Approved [386]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [387]
Beta-carotene DM0RXBT Vitamin deficiency 5B55-5B71 Approved [388]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [389]
Secobarbital DM14RF5 Epilepsy 8A60-8A68 Approved [390]
Gefitinib DM15F0X Colon adenocarcinoma Approved [391]
Fexofenadine DM17ONX Allergic rhinitis CA08.0 Approved [392]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [393]
Imiquimod DM1TMA3 Alopecia areata ED70.2 Approved [394]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Ethanol DMDRQZU Chronic pain MG30 Approved [395]
Progesterone DMUY35B Amenorrhea GA20.0 Approved [386]
Carvedilol DMHTEAO Chronic heart failure BD1Z Approved [396]
Paclitaxel DMLB81S Breast carcinoma Approved [397]
Etoposide DMNH3PG Acute myelogenous leukaemia 2A41 Approved [398]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [385]
Urokinase DM0GOUD Myocardial infarction BA41-BA43 Approved [114]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [182]
Beta-carotene DM0RXBT Vitamin deficiency 5B55-5B71 Approved [388]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [389]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [128]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [399]
Nitric Oxide DM1RBYG Hypertension BA00-BA04 Approved [400]
Methotrexate DM2TEOL Anterior urethra cancer Approved [219]
Quercetin DM3NC4M Obesity 5B81 Approved [131]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [132]
Chlorpromazine DMBGZI3 Acute intermittent hepatic porphyria 5C58.11 Approved [401]
Thalidomide DM70BU5 Adult T-cell leukemia/lymphoma Approved [215]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [204]
Testosterone DM7HUNW Hot flushes GA30 Approved [169]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [142]
Triacetin DM0AEPG Onychomycosis EE12.1 Approved [402]
Bepridil DM0RKS4 Chronic/stable angina BA40.1 Approved [362]
Indinavir DM0T3YH Human immunodeficiency virus infection 1C62 Approved [207]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [310]
Colchicine DM2POTE Acute gout flare FA25.0 Approved [403]
Sulindac DM2QHZU Acute myelogenous leukaemia 2A41 Approved [404]
Methotrexate DM2TEOL Anterior urethra cancer Approved [213]
Quercetin DM3NC4M Obesity 5B81 Approved [131]
Furazolidone DM3P6V7 Diarrhea ME05.1 Approved [405]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [140]
Selenium DM25CGV N. A. N. A. Approved [137]
Methotrexate DM2TEOL Anterior urethra cancer Approved [149]
Quercetin DM3NC4M Obesity 5B81 Approved [131]
obeticholic acid DM3Q1SM Primary biliary cholangitis DB96.1 Approved [153]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [162]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [406]
Leflunomide DMR8ONJ Arthritis FA20 Approved [221]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [170]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [194]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Nicotine DMWX5CO Lung cancer 2C25.0 Approved [407]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [408]
Gefitinib DM15F0X Colon adenocarcinoma Approved [371]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [409]
Ribavirin DMEYLH9 Hepatitis C virus infection 1E51.1 Approved [250]
Colchicine DM2POTE Acute gout flare FA25.0 Approved [410]
Quercetin DM3NC4M Obesity 5B81 Approved [411]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [412]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [413]
Gabapentin DM6T924 Complex partial seizure 8A68.0 Approved [410]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Caspase-3 (CASP3)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Sevoflurane DMC9O43 Anaesthesia 9A78.6 Approved [414]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [415]
Lovastatin DM9OZWQ Arteriosclerosis BD40 Approved [416]
Cidofovir DMA13GD Cytomegalovirus infection 1D82 Approved [417]
Docetaxel DMDI269 Advanced cancer 2A00-2F9Z Approved [418]
Etoposide DMNH3PG Acute myelogenous leukaemia 2A41 Approved [419]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [420]
Mannitol DMSCDY9 Bronchiectasis CA24 Approved [421]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [422]
Aprepitant DM053KT Depression 6A70-6A7Z Approved [423]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [125]
Dihydrotestosterone DM3S8XC Prostate hyperplasia GA90 Phase 4 [424]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [197]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [425]
AHPN DM8G6O4 Discovery agent N.A. Investigative [426]
Drug(s) Affected By Caspase-4 (CASP4)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [182]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [294]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [140]
Quercetin DM3NC4M Obesity 5B81 Approved [427]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [428]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [429]
Testosterone DM7HUNW Hot flushes GA30 Approved [220]
Acocantherin DM7JT24 Atrial fibrillation BC81.3 Approved [430]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [406]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [125]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [131]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [375]
Testosterone DM7HUNW Hot flushes GA30 Approved [169]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [169]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [125]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [139]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [127]
Capsaicin DMGMF6V Back pain ME84.Z Approved [431]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [432]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [433]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Caspase-7 (CASP7)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [434]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [435]
Nitric Oxide DM1RBYG Hypertension BA00-BA04 Approved [436]
Spironolactone DM2AQ5N Chronic heart failure BD1Z Approved [437]
Imipramine DM2NUH3 Depression 6A70-6A7Z Approved [437]
Methotrexate DM2TEOL Anterior urethra cancer Approved [201]
Dactinomycin DM2YGNW Adult kidney Wilms tumor Approved [253]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [438]
Lapatinib DM3BH1Y Breast cancer 2C60-2C65 Approved [439]
Cladribine DM3JDRP Hairy cell leukaemia 2A82.2 Approved [440]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [204]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [125]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [127]
Menadione DMSJDTY Vitamin K deficiency 5B59 Approved [140]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [441]
Nicotine DMWX5CO Lung cancer 2C25.0 Approved [442]
Phenobarbital DMXZOCG Cluster headache 8A81.0 Approved [443]
Urethane DM7NSI0 N. A. N. A. Phase 4 [263]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [444]
Milchsaure DM462BT Pruritus EC90 Investigative [445]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [124]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [361]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [194]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [127]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [446]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [195]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [441]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [281]
Phenobarbital DMXZOCG Cluster headache 8A81.0 Approved [443]
Urethane DM7NSI0 N. A. N. A. Phase 4 [263]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [170]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [139]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [127]
Clozapine DMFC71L Schizophrenia 6A20 Approved [447]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [446]
Piroxicam DMTK234 Osteoarthritis FA00-FA05 Approved [448]
Arsenic DMTL2Y1 N. A. N. A. Approved [449]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [196]
Carbamazepine DMZOLBI Epilepsy 8A60-8A68 Approved [450]
Urethane DM7NSI0 N. A. N. A. Phase 4 [263]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [182]
Methotrexate DM2TEOL Anterior urethra cancer Approved [201]
Quercetin DM3NC4M Obesity 5B81 Approved [131]
obeticholic acid DM3Q1SM Primary biliary cholangitis DB96.1 Approved [153]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [124]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [412]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [451]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [125]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [126]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [127]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [452]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [140]
Methotrexate DM2TEOL Anterior urethra cancer Approved [123]
Quercetin DM3NC4M Obesity 5B81 Approved [453]
Acetic Acid, Glacial DM4SJ5Y infection in the ear canal AA0Y Approved [358]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [237]
Thalidomide DM70BU5 Adult T-cell leukemia/lymphoma Approved [215]
Testosterone DM7HUNW Hot flushes GA30 Approved [169]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [169]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [125]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Beta-carotene DM0RXBT Vitamin deficiency 5B55-5B71 Approved [160]
Ciprofloxacin XR DM2NLS9 Acute gonococcal cervicitis Approved [454]
Methotrexate DM2TEOL Anterior urethra cancer Approved [455]
Dactinomycin DM2YGNW Adult kidney Wilms tumor Approved [456]
Quercetin DM3NC4M Obesity 5B81 Approved [457]
Penicillamine DM40EF6 Cystinuria 5C60.2 Approved [285]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [160]
Glucosamine DM4ZLFD Osteoarthritis FA00-FA05 Approved [458]
Ethacrynic acid DM60QMR Edema MG29 Approved [459]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [460]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Metoclopramide DMFA5MY Nausea MD90 Approved [461]
Quinidine DMLPICK N. A. N. A. Approved [462]
Verapamil DMA7PEW Angina pectoris BA40 Approved [463]
Erythromycin DM4K7GQ Acne vulgaris ED80 Approved [464]
Clarithromycin DM4M1SG Acute maxillary sinusitis Approved [464]
Disopyramide DM5SYZP Long QT syndrome BC65.0 Approved [465]
Propranolol DM79NTF Angina pectoris BA40 Approved [466]
Amiodarone DMUTEX3 Tachyarrhythmias BC71 Approved [467]
Dofetilide DMPN1TW Sinus rhythm disorder BC9Y Approved [468]
Flecainide DMSQDLE Tachyarrhythmias BC71 Approved [464]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [233]
Sulindac DM2QHZU Acute myelogenous leukaemia 2A41 Approved [207]
Quercetin DM3NC4M Obesity 5B81 Approved [457]
obeticholic acid DM3Q1SM Primary biliary cholangitis DB96.1 Approved [153]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [172]
Crizotinib DM4F29C Non-small-cell lung cancer 2C25.Y Approved [469]
Zidovudine DM4KI7O Human immunodeficiency virus infection 1C62 Approved [470]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [471]
Glucosamine DM4ZLFD Osteoarthritis FA00-FA05 Approved [472]
Aspirin DM672AH Acute coronary syndrome BA41 Approved [473]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Selenium DM25CGV N. A. N. A. Approved [137]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [237]
Thalidomide DM70BU5 Adult T-cell leukemia/lymphoma Approved [215]
Leflunomide DMR8ONJ Arthritis FA20 Approved [221]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [170]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [139]
Febuxostat DMDEXQ0 Hyperuricaemia 5C55.Y Approved [474]
Niclosamide DMJAGXQ Cestodes infection 1F70-1F76 Approved [475]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [195]
Arsenic DMTL2Y1 N. A. N. A. Approved [476]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Sequestosome-1 (SQSTM1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [408]
Gefitinib DM15F0X Colon adenocarcinoma Approved [477]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [161]
Trametinib DM2JGQ3 Melanoma 2C30 Approved [478]
Sulindac DM2QHZU Acute myelogenous leukaemia 2A41 Approved [144]
Methotrexate DM2TEOL Anterior urethra cancer Approved [201]
Quercetin DM3NC4M Obesity 5B81 Approved [131]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [146]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [479]
Nefazodone DM4ZS8M Major depressive disorder 6A70.3 Approved [359]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Cullin-1 (CUL1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [375]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [412]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [139]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [127]
Bortezomib DMNO38U Leukemia Approved [480]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [195]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [196]
Tamibarotene DM3G74J T-cell leukaemia 2A90 Phase 3 [375]
DNCB DMDTVYC Immune System disease 4A01-4B41 Phase 2 [481]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [197]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [142]
Sulindac DM2QHZU Acute myelogenous leukaemia 2A41 Approved [482]
Quercetin DM3NC4M Obesity 5B81 Approved [131]
Nefazodone DM4ZS8M Major depressive disorder 6A70.3 Approved [359]
Thalidomide DM70BU5 Adult T-cell leukemia/lymphoma Approved [215]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [204]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [483]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [194]
Racecadotril DMFOTZ7 Diarrhea ME05.1 Approved [484]
Amiodarone DMUTEX3 Tachyarrhythmias BC71 Approved [485]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Selenium DM25CGV N. A. N. A. Approved [137]
Ergotidine DM78IME Osteoarthritis FA00-FA05 Approved [486]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [139]
2-deoxyglucose DMIAHVU Solid tumour/cancer 2A00-2F9Z Approved [487]
Pioglitazone DMKJ485 Amyotrophic lateral sclerosis 8B60.0 Approved [488]
Arsenic DMTL2Y1 N. A. N. A. Approved [222]
Resveratrol DM3RWXL Giant cell arteritis 4A44.2 Phase 3 [489]
APR-246 DMNFADH Ovarian cancer 2C73 Phase 2 [490]
GDC-0980/RG7422 DMF3MV1 Non-hodgkin lymphoma 2B33.5 Phase 2 [491]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [492]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [493]
Verapamil DMA7PEW Angina pectoris BA40 Approved [494]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [495]
Selenium DM25CGV N. A. N. A. Approved [137]
TECFIDERA DM2OVDT Multiple sclerosis 8A40 Approved [496]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [497]
Lapatinib DM3BH1Y Breast cancer 2C60-2C65 Approved [498]
Quercetin DM3NC4M Obesity 5B81 Approved [131]
Furazolidone DM3P6V7 Diarrhea ME05.1 Approved [499]
obeticholic acid DM3Q1SM Primary biliary cholangitis DB96.1 Approved [153]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [125]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [127]
Arsenic DMTL2Y1 N. A. N. A. Approved [222]
Progesterone DMUY35B Amenorrhea GA20.0 Approved [500]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [281]
Sodium phenylbutyrate DMXLBCQ Spinal muscular atrophy 8B61 Approved [501]
Dihydrotestosterone DM3S8XC Prostate hyperplasia GA90 Phase 4 [424]
Urethane DM7NSI0 N. A. N. A. Phase 4 [263]
THAPSIGARGIN DMDMQIE N. A. N. A. Preclinical [199]
3R14S-OCHRATOXIN A DM2KEW6 Discovery agent N.A. Investigative [502]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [503]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [146]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [172]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [237]
Leflunomide DMR8ONJ Arthritis FA20 Approved [221]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [125]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [139]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [504]
Arsenic DMTL2Y1 N. A. N. A. Approved [505]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [196]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [409]
Methotrexate DM2TEOL Anterior urethra cancer Approved [201]
Quercetin DM3NC4M Obesity 5B81 Approved [131]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [506]
Nefazodone DM4ZS8M Major depressive disorder 6A70.3 Approved [359]
Rifampicin DM5DSFZ Non-insulin dependent diabetes 5A11 Approved [507]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [508]
Trovafloxacin DM6AN32 Acute gonococcal cervicitis Approved [509]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [413]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [510]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Imipramine DM2NUH3 Depression 6A70-6A7Z Approved [511]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [194]
Diclofenac DMPIHLS Chronic renal failure GB61.Z Approved [226]
Arsenic DMTL2Y1 N. A. N. A. Approved [222]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [441]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [281]
Carbamazepine DMZOLBI Epilepsy 8A60-8A68 Approved [226]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [512]
PMID28870136-Compound-52 DMFDERP N. A. N. A. Patented [513]
COUMARIN DM0N8ZM Discovery agent N.A. Investigative [513]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [205]
Indinavir DM0T3YH Human immunodeficiency virus infection 1C62 Approved [207]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [140]
Sulindac DM2QHZU Acute myelogenous leukaemia 2A41 Approved [207]
Quercetin DM3NC4M Obesity 5B81 Approved [514]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [207]
Pyrazinamide DM4IF32 Meningeal tuberculosis Approved [209]
Glucosamine DM4ZLFD Osteoarthritis FA00-FA05 Approved [210]
Rifampicin DM5DSFZ Non-insulin dependent diabetes 5A11 Approved [363]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [211]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Methotrexate DM2TEOL Anterior urethra cancer Approved [123]
Leflunomide DMR8ONJ Arthritis FA20 Approved [221]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [139]
Clozapine DMFC71L Schizophrenia 6A20 Approved [447]
Arsenic DMTL2Y1 N. A. N. A. Approved [515]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [516]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [281]
Urethane DM7NSI0 N. A. N. A. Phase 4 [263]
(+)-JQ1 DM1CZSJ Testicular cancer 2C80 Phase 1 [517]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [197]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [139]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [433]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [516]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [197]
PMID28870136-Compound-52 DMFDERP N. A. N. A. Patented [513]
Glyphosate DM0AFY7 Malaria 1F40-1F45 Investigative [200]
⏷ Show the Full List of 6 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Methotrexate DM2TEOL Anterior urethra cancer Approved [219]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [135]
Cyclophosphamide DM4O2Z7 Advanced cancer 2A00-2F9Z Approved [518]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [135]
Panobinostat DM58WKG Chronic graft versus host disease Approved [155]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [518]
Thalidomide DM70BU5 Adult T-cell leukemia/lymphoma Approved [215]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [406]
Leflunomide DMR8ONJ Arthritis FA20 Approved [221]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [125]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Paroxetine DM5PVQE Anxiety disorder 6B00-6B0Z Approved [519]
Fluoxetine DM3PD2C Bipolar depression Approved [520]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [140]
Ribavirin DMEYLH9 Hepatitis C virus infection 1E51.1 Approved [521]
Colchicine DM2POTE Acute gout flare FA25.0 Approved [410]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [522]
Quercetin DM3NC4M Obesity 5B81 Approved [131]
Aripiprazole DM3NUMH Bipolar I disorder Approved [523]
Gabapentin DM6T924 Complex partial seizure 8A68.0 Approved [410]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [170]
⏷ Show the Full List of 10 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Serotonin transporter (SERT) TT3ROYC SC6A4_HUMAN Inhibitor [3]

Drug Transporter (DTP)
DTP Name DTP ID UniProt ID MOA REF
P-glycoprotein 1 (ABCB1) DTUGYRD MDR1_HUMAN Substrate [4]

Drug-Metabolizing Enzyme (DME)
DME Name DME ID UniProt ID MOA REF
Cytochrome P450 3A4 (CYP3A4) Main DME DE4LYSA CP3A4_HUMAN Substrate [5]
Cytochrome P450 2E1 (CYP2E1) DEVDYN7 CP2E1_HUMAN Substrate [6]
Cytochrome P450 2D6 (CYP2D6) DECB0K3 CP2D6_HUMAN Substrate [7]
Cytochrome P450 2C9 (CYP2C9) DE5IED8 CP2C9_HUMAN Substrate [8]
Mephenytoin 4-hydroxylase (CYP2C19) DEGTFWK CP2CJ_HUMAN Substrate [9]
Cytochrome P450 1A2 (CYP1A2) DEJGDUW CP1A2_HUMAN Substrate [10]
Cytochrome P450 2B6 (CYP2B6) Main DME DEPKLMQ CP2B6_HUMAN Substrate [9]

Drug Off-Target (DOT)
DOT Name DOT ID UniProt ID Interaction REF
Acetyl-CoA carboxylase 1 (ACACA) OT5CQPZY ACACA_HUMAN Post-Translational Modifications [11]
Acid ceramidase (ASAH1) OT1DNGXL ASAH1_HUMAN Gene/Protein Processing [12]
Albumin (ALB) OTVMM513 ALBU_HUMAN Protein Interaction/Cellular Processes [13]
Alpha-1-antichymotrypsin (SERPINA3) OT9BP2S0 AACT_HUMAN Gene/Protein Processing [12]
Alpha-crystallin A chain (CRYAA) OTSN7JUR CRYAA_HUMAN Gene/Protein Processing [14]
Apoptosis regulator Bcl-2 (BCL2) OT9DVHC0 BCL2_HUMAN Gene/Protein Processing [15]
Aromatase (CYP19A1) OTZ6XF74 CP19A_HUMAN Gene/Protein Processing [16]
Asparagine synthetase (ASNS) OT8R922G ASNS_HUMAN Gene/Protein Processing [12]
ATP-dependent translocase ABCB1 (ABCB1) OTEJROBO MDR1_HUMAN Gene/Protein Processing [17]
C-Jun-amino-terminal kinase-interacting protein 3 (MAPK8IP3) OT0X8ACY JIP3_HUMAN Gene/Protein Processing [14]

References

1 Sertraline FDA Label
2 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4798).
3 Psychopharmacological treatment of dermatological patients--when simply talking does not help. J Dtsch Dermatol Ges. 2007 Dec;5(12):1101-6.
4 Improving the prediction of the brain disposition for orally administered drugs using BDDCS. Adv Drug Deliv Rev. 2012 Jan;64(1):95-109.
5 New orally active anticoagulant agents for the prevention and treatment of venous thromboembolism in cancer patients. Ther Clin Risk Manag. 2014 Jun 13;10:423-36.
6 PharmGKB: A worldwide resource for pharmacogenomic information. Wiley Interdiscip Rev Syst Biol Med. 2018 Jul;10(4):e1417. (ID: PA166181117)
7 Some aspects of genetic polymorphism in the biotransformation of antidepressants. Therapie. 2004 Jan-Feb;59(1):5-12.
8 Sertraline is metabolized by multiple cytochrome P450 enzymes, monoamine oxidases, and glucuronyl transferases in human: an in vitro study. Drug Metab Dispos. 2005 Feb;33(2):262-70.
9 Influence of CYP2B6 and CYP2C19 polymorphisms on sertraline metabolism in major depression patients. Int J Clin Pharm. 2016 Apr;38(2):388-94.
10 The selective serotonin reuptake inhibitor sertraline: its profile and use in psychiatric disorders. CNS Drug Rev. 2001 Spring;7(1):1-24.
11 Antidepressant drug sertraline modulates AMPK-MTOR signaling-mediated autophagy via targeting mitochondrial VDAC1 protein. Autophagy. 2021 Oct;17(10):2783-2799. doi: 10.1080/15548627.2020.1841953. Epub 2020 Nov 9.
12 A toxicogenomic approach to drug-induced phospholipidosis: analysis of its induction mechanism and establishment of a novel in vitro screening system. Toxicol Sci. 2005 Feb;83(2):282-92.
13 Exploring binding properties of sertraline with human serum albumin: Combination of spectroscopic and molecular modeling studies. Chem Biol Interact. 2015 Dec 5;242:235-46. doi: 10.1016/j.cbi.2015.10.006. Epub 2015 Oct 22.
14 Sertraline induces endoplasmic reticulum stress in hepatic cells. Toxicology. 2014 Aug 1;322:78-88. doi: 10.1016/j.tox.2014.05.007. Epub 2014 May 24.
15 Sertraline, an antidepressant, induces apoptosis in hepatic cells through the mitogen-activated protein kinase pathway. Toxicol Sci. 2014 Feb;137(2):404-15. doi: 10.1093/toxsci/kft254. Epub 2013 Nov 5.
16 Effects of selective serotonin reuptake inhibitors on three sex steroids in two versions of the aromatase enzyme inhibition assay and in the H295R cell assay. Toxicol In Vitro. 2015 Oct;29(7):1729-35.
17 Michaelis-Menten kinetic analysis of drugs of abuse to estimate their affinity to human P-glycoprotein. Toxicol Lett. 2013 Feb 27;217(2):137-42. doi: 10.1016/j.toxlet.2012.12.012. Epub 2012 Dec 27.
18 Augmentation effect of combination therapy of aripiprazole and antidepressants on forced swimming test in mice. Psychopharmacology (Berl). 2009 Sep;206(1):97-107.
19 Treatment of comorbid pain with serotonin norepinephrine reuptake inhibitors. CNS Spectr. 2008 Jul;13(7 Suppl 11):22-6.
20 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services.
21 Radium 223 dichloride for prostate cancer treatment. Drug Des Devel Ther. 2017 Sep 6;11:2643-2651.
22 Differential involvement of the norepinephrine, serotonin and dopamine reuptake transporter proteins in cocaine-induced taste aversion. Pharmacol Biochem Behav. 2009 Jul;93(1):75-81.
23 Clinically relevant drug interactions with new generation antidepressants and antipsychotics. Ther Umsch. 2009 Jun;66(6):485-92.
24 Human intestinal transporter database: QSAR modeling and virtual profiling of drug uptake, efflux and interactions. Pharm Res. 2013 Apr;30(4):996-1007.
25 MDR1 (ABCB1) G1199A (Ser400Asn) polymorphism alters transepithelial permeability and sensitivity to anticancer agents. Cancer Chemother Pharmacol. 2009 Jun;64(1):183-8.
26 Mammalian drug efflux transporters of the ATP binding cassette (ABC) family in multidrug resistance: A review of the past decade. Cancer Lett. 2016 Jan 1;370(1):153-64.
27 Folate transporter expression decreases in the human placenta throughout pregnancy and in pre-eclampsia. Pregnancy Hypertens. 2012 Apr;2(2):123-31.
28 Comparative studies on in vitro methods for evaluating in vivo function of MDR1 P-glycoprotein. Pharm Res. 2001 Dec;18(12):1660-8.
29 Antiestrogens and steroid hormones: substrates of the human P-glycoprotein. Biochem Pharmacol. 1994 Jul 19;48(2):287-92.
30 Association of genetic polymorphisms in the influx transporter SLCO1B3 and the efflux transporter ABCB1 with imatinib pharmacokinetics in patients with chronic myeloid leukemia. Ther Drug Monit. 2011 Apr;33(2):244-50.
31 Expression levels and activation of a PXR variant are directly related to drug resistance in osteosarcoma cell lines. Cancer. 2007 Mar 1;109(5):957-65.
32 Contribution of human hepatic cytochrome P450 isoforms to regioselective hydroxylation of steroid hormones. Xenobiotica. 1998 Jun;28(6):539-47.
33 Comprehensive evaluation of tamoxifen sequential biotransformation by the human cytochrome P450 system in vitro: prominent roles for CYP3A and CYP2D6. J Pharmacol Exp Ther. 2004 Sep;310(3):1062-75.
34 Isoform-specific regulation of cytochromes P450 expression by estradiol and progesterone. Drug Metab Dispos. 2013 Feb;41(2):263-9.
35 Metabolic interactions between acetaminophen (paracetamol) and two flavonoids, luteolin and quercetin, through in-vitro inhibition studies. J Pharm Pharmacol. 2017 Dec;69(12):1762-1772.
36 Potent mechanism-based inhibition of CYP3A4 by imatinib explains its liability to interact with CYP3A4 substrates. Br J Pharmacol. 2012 Apr;165(8):2787-98.
37 Effects of morin on the pharmacokinetics of etoposide in rats. Biopharm Drug Dispos. 2007 Apr;28(3):151-6.
38 The metabolism of zidovudine by human liver microsomes in vitro: formation of 3'-amino-3'-deoxythymidine. Biochem Pharmacol. 1994 Jul 19;48(2):267-76.
39 Substrates, inducers, inhibitors and structure-activity relationships of human Cytochrome P450 2C9 and implications in drug development. Curr Med Chem. 2009;16(27):3480-675.
40 Roles of cytochromes P450 1A2, 2A6, and 2C8 in 5-fluorouracil formation from tegafur, an anticancer prodrug, in human liver microsomes. Drug Metab Dispos. 2000 Dec;28(12):1457-63.
41 Effects of polyunsaturated fatty acids on prostaglandin synthesis and cyclooxygenase-mediated DNA adduct formation by heterocyclic aromatic amines in human adenocarcinoma colon cells. Mol Carcinog. 2004 Jul;40(3):180-8.
42 Endoxifen and other metabolites of tamoxifen inhibit human hydroxysteroid sulfotransferase 2A1 (hSULT2A1). Drug Metab Dispos. 2014 Nov;42(11):1843-50.
43 Cytochrome P450 1A2 (CYP1A2) activity and risk factors for breast cancer: a cross-sectional study. Breast Cancer Res. 2004;6(4):R352-65.
44 PharmGKB summary: pathways of acetaminophen metabolism at the therapeutic versus toxic doses. Pharmacogenet Genomics. 2015 Aug;25(8):416-26.
45 The effect of apigenin on pharmacokinetics of imatinib and its metabolite N-desmethyl imatinib in rats. Biomed Res Int. 2013;2013:789184.
46 The influence of metabolic gene polymorphisms on urinary 1-hydroxypyrene concentrations in Chinese coke oven workers. Sci Total Environ. 2007 Aug 1;381(1-3):38-46.
47 Identification of P450 enzymes involved in metabolism of verapamil in humans. Naunyn Schmiedebergs Arch Pharmacol. 1993 Sep;348(3):332-7.
48 Metabolism and metabolic inhibition of xanthotoxol in human liver microsomes. Evid Based Complement Alternat Med. 2016;2016:5416509.
49 Inhibitory effects of anticancer drugs on dextromethorphan-O-demethylase activity in human liver microsomes. Cancer Chemother Pharmacol. 1993;32(6):491-5.
50 Effect of genetic polymorphism on the metabolism of endogenous neuroactive substances, progesterone and p-tyramine, catalyzed by CYP2D6. Brain Res Mol Brain Res. 2004 Oct 22;129(1-2):117-23.
51 CYP2D6 polymorphisms and tamoxifen metabolism: clinical relevance. Curr Oncol Rep. 2010 Jan;12(1):7-15.
52 Inhibition of cytochrome P450 2D6: structure-activity studies using a series of quinidine and quinine analogues. Chem Res Toxicol. 2003 Apr;16(4):450-9.
53 Effects of propofol on human hepatic microsomal cytochrome P450 activities. Xenobiotica. 1998 Sep;28(9):845-53.
54 Pharmacogenetics of schizophrenia. Am J Med Genet. 2000 Spring;97(1):98-106.
55 Roles of CYP2A6 and CYP2B6 in nicotine C-oxidation by human liver microsomes. Arch Toxicol. 1999 Mar;73(2):65-70.
56 Structure-activity relationship for human cytochrome P450 substrates and inhibitors. Drug Metab Rev. 2002 Feb-May;34(1-2):69-82.
57 Chronic ethanol feeding and folate deficiency activate hepatic endoplasmic reticulum stress pathway in micropigs. Am J Physiol Gastrointest Liver Physiol. 2005 Jul;289(1):G54-63.
58 Cytochrome P450 2E1 null mice provide novel protection against cisplatin-induced nephrotoxicity and apoptosis. Kidney Int. 2003 May;63(5):1687-96.
59 Genotoxicity of tamoxifen, tamoxifen epoxide and toremifene in human lymphoblastoid cells containing human cytochrome P450s. Carcinogenesis. 1994 Jan;15(1):5-9.
60 Acetaminophen induced acute liver failure via oxidative stress and JNK activation: protective role of taurine by the suppression of cytochrome P450 2E1. Free Radic Res. 2010 Mar;44(3):340-55.
61 A study on the metabolism of etoposide and possible interactions with antitumor or supporting agents by human liver microsomes. J Pharmacol Exp Ther. 1998 Sep;286(3):1294-300.
62 Summary of information on human CYP enzymes: human P450 metabolism data. Drug Metab Rev. 2002 Feb-May;34(1-2):83-448.
63 Novel metabolic pathway of estrone and 17beta-estradiol catalyzed by cytochrome P-450. Drug Metab Dispos. 2000 Feb;28(2):110-2.
64 Inhibition of cytochrome P450 2E1 by propofol in human and porcine liver microsomes. Biochem Pharmacol. 2002 Oct 1;64(7):1151-6.
65 CYP2E1 and clinical features in alcoholics. Neuropsychobiology. 2003;47(2):86-9.
66 Progesterone and testosterone hydroxylation by cytochromes P450 2C19, 2C9, and 3A4 in human liver microsomes. Arch Biochem Biophys. 1997 Oct 1;346(1):161-9.
67 Tamoxifen inhibits cytochrome P450 2C9 activity in breast cancer patients. J Chemother. 2006 Aug;18(4):421-4.
68 Characterization of the oxidative metabolites of 17beta-estradiol and estrone formed by 15 selectively expressed human cytochrome p450 isoforms. Endocrinology. 2003 Aug;144(8):3382-98.
69 Drug-drug interactions with imatinib: an observational study. Medicine (Baltimore). 2016 Oct;95(40):e5076.
70 Drug interactions with calcium channel blockers: possible involvement of metabolite-intermediate complexation with CYP3A. Drug Metab Dispos. 2000 Feb;28(2):125-30.
71 New insights into the structural features and functional relevance of human cytochrome P450 2C9. Part I. Curr Drug Metab. 2009 Dec;10(10):1075-126.
72 A potential role for the estrogen-metabolizing cytochrome P450 enzymes in human breast carcinogenesis. Breast Cancer Res Treat. 2003 Dec;82(3):191-7.
73 A mechanistic approach to antiepileptic drug interactions. Ann Pharmacother. 1998 May;32(5):554-63.
74 Effect of tamoxifen on the enzymatic activity of human cytochrome CYP2B6. J Pharmacol Exp Ther. 2002 Jun;301(3):945-52.
75 Hepatic metabolism of diclofenac: role of human CYP in the minor oxidative pathways. Biochem Pharmacol. 1999 Sep 1;58(5):787-96.
76 Insights into CYP2B6-mediated drug-drug interactions. Acta Pharm Sin B. 2016 Sep;6(5):413-425.
77 Drugs that may have potential CYP2B6 interactions.
78 Involvement of human cytochrome P450 2B6 in the omega- and 4-hydroxylation of the anesthetic agent propofol. Xenobiotica. 2007 Jul;37(7):717-24.
79 Nicotine and 4-(methylnitrosamino)-1-(3-pyridyl)-butanone metabolism by cytochrome P450 2B6. Drug Metab Dispos. 2005 Dec;33(12):1760-4.
80 PharmGKB summary: phenytoin pathway. Pharmacogenet Genomics. 2012 Jun;22(6):466-70.
81 Application of the relative activity factor approach in scaling from heterologously expressed cytochromes p450 to human liver microsomes: studies on amitriptyline as a model substrate. J Pharmacol Exp Ther. 2001 Apr;297(1):326-37.
82 High-dose rabeprazole/amoxicillin therapy as the second-line regimen after failure to eradicate H. pylori by triple therapy with the usual doses of a proton pump inhibitor, clarithromycin and amoxicillin. Hepatogastroenterology. 2003 Nov-Dec;50(54):2274-8.
83 Cytochrome P450 pharmacogenetics and cancer. Oncogene. 2006 Mar 13;25(11):1679-91.
84 CYP2C19*17 is associated with decreased breast cancer risk. Breast Cancer Res Treat. 2009 May;115(2):391-6.
85 Cytochromes of the P450 2C subfamily are the major enzymes involved in the O-demethylation of verapamil in humans. Naunyn Schmiedebergs Arch Pharmacol. 1995 Dec;353(1):116-21.
86 Diclofenac and its derivatives as tools for studying human cytochromes P450 active sites: particular efficiency and regioselectivity of P450 2Cs. Biochemistry. 1999 Oct 26;38(43):14264-70.
87 Organic anion-transporting polypeptide B (OATP-B) and its functional comparison with three other OATPs of human liver. Gastroenterology. 2001 Feb;120(2):525-33.
88 Possible involvement of multiple human cytochrome P450 isoforms in the liver metabolism of propofol. Br J Anaesth. 1998 Jun;80(6):788-95.
89 Transcriptional profiling suggests that Nevirapine and Ritonavir cause drug induced liver injury through distinct mechanisms in primary human hepatocytes. Chem Biol Interact. 2016 Aug 5;255:31-44.
90 Evaluation of gene induction of drug-metabolizing enzymes and transporters in primary culture of human hepatocytes using high-sensitivity real-time reverse transcription PCR. Yakugaku Zasshi. 2002 May;122(5):339-61.
91 Thalidomide increases human hepatic cytochrome P450 3A enzymes by direct activation of the pregnane X receptor. Chem Res Toxicol. 2014 Feb 17;27(2):304-308.
92 Human constitutive androstane receptor mediates induction of CYP2B6 gene expression by phenytoin. J Biol Chem. 2004 Jul 9;279(28):29295-301. doi: 10.1074/jbc.M400580200. Epub 2004 Apr 28.
93 Identification of novel agonists by high-throughput screening and molecular modelling of human constitutive androstane receptor isoform 3. Arch Toxicol. 2019 Aug;93(8):2247-2264. doi: 10.1007/s00204-019-02495-6. Epub 2019 Jul 16.
94 Antimalarial artemisinin drugs induce cytochrome P450 and MDR1 expression by activation of xenosensors pregnane X receptor and constitutive androstane receptor. Mol Pharmacol. 2005 Jun;67(6):1954-65.
95 Characterization of human cytochrome P450 induction by pesticides. Toxicology. 2012 Mar 29;294(1):17-26.
96 Species-specific mechanisms for cholesterol 7alpha-hydroxylase (CYP7A1) regulation by drugs and bile acids. Arch Biochem Biophys. 2005 Feb 1;434(1):75-85.
97 Pyrethroids: cytotoxicity and induction of CYP isoforms in human hepatocytes. Drug Metabol Drug Interact. 2008;23(3-4):211-36.
98 Transcriptional profiling of genes induced in the livers of patients treated with carbamazepine. Clin Pharmacol Ther. 2006 Nov;80(5):440-456.
99 Human recombinant cytochrome P450 enzymes display distinct hydrogen peroxide generating activities during substrate independent NADPH oxidase reactions. Toxicol Sci. 2014 Oct;141(2):344-52. doi: 10.1093/toxsci/kfu133. Epub 2014 Jul 24.
100 Cytochrome P450 2D6 genotype and steady state plasma levels of risperidone and 9-hydroxyrisperidone. Psychopharmacology (Berl). 1999 Dec;147(3):300-5. doi: 10.1007/s002130051171.
101 Effect of penicillin-based antibiotics, amoxicillin, ampicillin, and piperacillin, on drug-metabolizing activities of human hepatic cytochromes P450. J Toxicol Sci. 2016 Feb;41(1):143-6.
102 Cannabidiol, a major phytocannabinoid, as a potent atypical inhibitor for CYP2D6. Drug Metab Dispos. 2011 Nov;39(11):2049-56. doi: 10.1124/dmd.111.041384. Epub 2011 Aug 5.
103 Identification of human P450 isoforms involved in the metabolism of the antiallergic drug, oxatomide, and its kinetic parameters and inhibition constants. Biol Pharm Bull. 2005 Feb;28(2):328-34.
104 Pharmacokinetics of desipramine HCl when administered with cinacalcet HCl. Eur J Clin Pharmacol. 2007 Feb;63(2):159-63.
105 Effects of capsaicin and dihydrocapsaicin on human and rat liver microsomal CYP450 enzyme activities in vitro and in vivo. J Asian Nat Prod Res. 2012;14(4):382-95.
106 Application of higher throughput screening (HTS) inhibition assays to evaluate the interaction of antiparasitic drugs with cytochrome P450s. Drug Metab Dispos. 2001 Jan;29(1):30-5.
107 Inhibition of cytochrome P4502D6 activity with paroxetine normalizes the ultrarapid metabolizer phenotype as measured by nortriptyline pharmacokinetics and the debrisoquin test. Clin Pharmacol Ther. 2001 Oct;70(4):327-35.
108 Interaction of buprenorphine and its metabolite norbuprenorphine with cytochromes p450 in vitro. Drug Metab Dispos. 2003 Jun;31(6):768-72.
109 Characterization of the structural determinants required for potent mechanism-based inhibition of human cytochrome P450 1A1 by cannabidiol. Chem Biol Interact. 2014 May 25;215:62-8.
110 Inhibition of cytochrome P450 enzymes participating in p-nitrophenol hydroxylation by drugs known as CYP2E1 inhibitors. Chem Biol Interact. 2004 Apr 15;147(3):331-40.
111 The novel azole R126638 is a selective inhibitor of ergosterol synthesis in Candida albicans, Trichophyton spp., and Microsporum canis. Antimicrob Agents Chemother. 2004 Sep;48(9):3272-8.
112 Cytochrome P450 inhibition potential of new psychoactive substances of the tryptamine class. Toxicol Lett. 2016 Jan 22;241:82-94.
113 Stiripentol. Expert Opin Investig Drugs. 2005 Jul;14(7):905-11.
114 ADReCS-Target: target profiles for aiding drug safety research and application. Nucleic Acids Res. 2018 Jan 4;46(D1):D911-D917. doi: 10.1093/nar/gkx899.
115 Characteristics of P388/VMDRC.04, a simple, sensitive model for studying P-glycoprotein antagonists. Cancer Res. 1994 Feb 1;54(3):730-7.
116 Editor's Highlight: PlacentalDisposition and Effects of Crizotinib: An Ex Vivo Study in the Isolated Dual-Side Perfused Human Cotyledon. Toxicol Sci. 2017 Jun 1;157(2):500-509. doi: 10.1093/toxsci/kfx063.
117 Functional evaluation of polymorphisms in the human ABCB1 gene and the impact on clinical responses of antiepileptic drugs. Pharmacogenet Genomics. 2008 May;18(5):390-402. doi: 10.1097/FPC.0b013e3282f85e36.
118 Cepharanthine potently enhances the sensitivity of anticancer agents in K562 cells. Cancer Sci. 2005 Jun;96(6):372-6. doi: 10.1111/j.1349-7006.2005.00057.x.
119 Clinical pharmacokinetic monitoring of itraconazole is warranted in only a subset of patients. Ther Drug Monit. 2005 Jun;27(3):322-33. doi: 10.1097/01.ftd.0000150135.22645.ea.
120 Evaluation of antipsychotic drugs as inhibitors of multidrug resistance transporter P-glycoprotein. Psychopharmacology (Berl). 2006 Sep;187(4):415-23. doi: 10.1007/s00213-006-0437-9. Epub 2006 Jun 30.
121 Actions of the selective protein kinase C inhibitor PKC412 on B-chronic lymphocytic leukemia cells in vitro. Haematologica. 2002 Feb;87(2):167-76.
122 Characterization of the ATPase activity of the Mr 170,000 to 180,000 membrane glycoprotein (P-glycoprotein) associated with multidrug resistance in K562/ADM cells. Cancer Res. 1988 Sep 1;48(17):4926-32.
123 The contribution of methotrexate exposure and host factors on transcriptional variance in human liver. Toxicol Sci. 2007 Jun;97(2):582-94.
124 Transcriptional and Metabolic Dissection of ATRA-Induced Granulocytic Differentiation in NB4 Acute Promyelocytic Leukemia Cells. Cells. 2020 Nov 5;9(11):2423. doi: 10.3390/cells9112423.
125 Comparison of HepG2 and HepaRG by whole-genome gene expression analysis for the purpose of chemical hazard identification. Toxicol Sci. 2010 May;115(1):66-79.
126 Integrated 'omics analysis reveals new drug-induced mitochondrial perturbations in human hepatocytes. Toxicol Lett. 2018 Jun 1;289:1-13.
127 Quantitative proteomics reveals a broad-spectrum antiviral property of ivermectin, benefiting for COVID-19 treatment. J Cell Physiol. 2021 Apr;236(4):2959-2975. doi: 10.1002/jcp.30055. Epub 2020 Sep 22.
128 Cannabidiol enhances cytotoxicity of anti-cancer drugs in human head and neck squamous cell carcinoma. Sci Rep. 2020 Nov 26;10(1):20622. doi: 10.1038/s41598-020-77674-y.
129 Determination of phospholipidosis potential based on gene expression analysis in HepG2 cells. Toxicol Sci. 2007 Mar;96(1):101-14.
130 In vitro detection of drug-induced phospholipidosis using gene expression and fluorescent phospholipid based methodologies. Toxicol Sci. 2007 Sep;99(1):162-73.
131 Comparison of phenotypic and transcriptomic effects of false-positive genotoxins, true genotoxins and non-genotoxins using HepG2 cells. Mutagenesis. 2011 Sep;26(5):593-604.
132 Effect of retinoic acid on gene expression in human conjunctival epithelium: secretory phospholipase A2 mediates retinoic acid induction of MUC16. Invest Ophthalmol Vis Sci. 2005 Nov;46(11):4050-61.
133 Oxidative Stress Alters miRNA and Gene Expression Profiles in Villous First Trimester Trophoblasts. Biomed Res Int. 2015;2015:257090. doi: 10.1155/2015/257090. Epub 2015 Aug 3.
134 Rofecoxib modulates multiple gene expression pathways in a clinical model of acute inflammatory pain. Pain. 2007 Mar;128(1-2):136-47.
135 Retinoic acid and its 4-oxo metabolites are functionally active in human skin cells in vitro. J Invest Dermatol. 2005 Jul;125(1):143-53.
136 Effects of aspirin on metastasis-associated gene expression detected by cDNA microarray. Acta Pharmacol Sin. 2004 Oct;25(10):1327-33.
137 Selenium and vitamin E: cell type- and intervention-specific tissue effects in prostate cancer. J Natl Cancer Inst. 2009 Mar 4;101(5):306-20.
138 Identification of vitamin D3 target genes in human breast cancer tissue. J Steroid Biochem Mol Biol. 2016 Nov;164:90-97.
139 Integrative omics data analyses of repeated dose toxicity of valproic acid in vitro reveal new mechanisms of steatosis induction. Toxicology. 2018 Jan 15;393:160-170.
140 Global gene expression analysis reveals differences in cellular responses to hydroxyl- and superoxide anion radical-induced oxidative stress in caco-2 cells. Toxicol Sci. 2010 Apr;114(2):193-203. doi: 10.1093/toxsci/kfp309. Epub 2009 Dec 31.
141 Species-specific toxicity of diclofenac and troglitazone in primary human and rat hepatocytes. Chem Biol Interact. 2009 Apr 15;179(1):17-24.
142 Inhibiting Heat Shock Proteins Can Potentiate the Cytotoxic Effect of Cannabidiol in Human Glioma Cells. Anticancer Res. 2015 Nov;35(11):5827-37.
143 Comparative gene expression profiling reveals partially overlapping but distinct genomic actions of different antiestrogens in human breast cancer cells. J Cell Biochem. 2006 Aug 1;98(5):1163-84.
144 Expression profile analysis of colon cancer cells in response to sulindac or aspirin. Biochem Biophys Res Commun. 2002 Mar 29;292(2):498-512.
145 Antirheumatic drug response signatures in human chondrocytes: potential molecular targets to stimulate cartilage regeneration. Arthritis Res Ther. 2009;11(1):R15.
146 Effects of ciglitazone and troglitazone on the proliferation of human stomach cancer cells. World J Gastroenterol. 2009 Jan 21;15(3):310-20.
147 Kinetic analysis of the liver-type (GLUT2) and brain-type (GLUT3) glucose transporters in Xenopus oocytes: substrate specificities and effects of transport inhibitors. Biochem J. 1993 Mar 15;290 ( Pt 3)(Pt 3):701-6. doi: 10.1042/bj2900701.
148 Cannabidiol induces antioxidant pathways in keratinocytes by targeting BACH1. Redox Biol. 2020 Jan;28:101321. doi: 10.1016/j.redox.2019.101321. Epub 2019 Sep 5.
149 Global molecular effects of tocilizumab therapy in rheumatoid arthritis synovium. Arthritis Rheumatol. 2014 Jan;66(1):15-23.
150 Retinoic acid represses a cassette of candidate pluripotency chromosome 12p genes during induced loss of human embryonal carcinoma tumorigenicity. Biochim Biophys Acta. 2005 Oct 15;1731(1):48-56. doi: 10.1016/j.bbaexp.2005.08.006. Epub 2005 Sep 1.
151 Differential gene expression in human hepatocyte cell lines exposed to the antiretroviral agent zidovudine. Arch Toxicol. 2014 Mar;88(3):609-23. doi: 10.1007/s00204-013-1169-3. Epub 2013 Nov 30.
152 Molecular mechanisms of hepatotoxic cholestasis by clavulanic acid: Role of NRF2 and FXR pathways. Food Chem Toxicol. 2021 Dec;158:112664. doi: 10.1016/j.fct.2021.112664. Epub 2021 Nov 9.
153 Pharmacotoxicology of clinically-relevant concentrations of obeticholic acid in an organotypic human hepatocyte system. Toxicol In Vitro. 2017 Mar;39:93-103.
154 Transcriptomic analysis of untreated and drug-treated differentiated HepaRG cells over a 2-week period. Toxicol In Vitro. 2015 Dec 25;30(1 Pt A):27-35.
155 A transcriptome-based classifier to identify developmental toxicants by stem cell testing: design, validation and optimization for histone deacetylase inhibitors. Arch Toxicol. 2015 Sep;89(9):1599-618.
156 Unique signatures of stress-induced senescent human astrocytes. Exp Neurol. 2020 Dec;334:113466. doi: 10.1016/j.expneurol.2020.113466. Epub 2020 Sep 17.
157 Folate deficiency in normal human fibroblasts leads to altered expression of genes primarily linked to cell signaling, the cytoskeleton and extracellular matrix. J Nutr Biochem. 2007 Aug;18(8):541-52. doi: 10.1016/j.jnutbio.2006.11.002. Epub 2007 Feb 22.
158 Differentiation of human embryonic stem cells into smooth muscle cells in adherent monolayer culture. Biochem Biophys Res Commun. 2006 Dec 15;351(2):321-7. doi: 10.1016/j.bbrc.2006.09.171. Epub 2006 Oct 17.
159 Antitumor effect of the histone deacetylase inhibitor LAQ824 in combination with 13-cis-retinoic acid in human malignant melanoma. Mol Cancer Ther. 2007 Jan;6(1):70-81. doi: 10.1158/1535-7163.MCT-06-0125.
160 Beta-carotene and apocarotenals promote retinoid signaling in BEAS-2B human bronchioepithelial cells. Arch Biochem Biophys. 2006 Nov 1;455(1):48-60.
161 MS4A3-HSP27 target pathway reveals potential for haematopoietic disorder treatment in alimentary toxic aleukia. Cell Biol Toxicol. 2023 Feb;39(1):201-216. doi: 10.1007/s10565-021-09639-4. Epub 2021 Sep 28.
162 Development of a neural teratogenicity test based on human embryonic stem cells: response to retinoic acid exposure. Toxicol Sci. 2011 Dec;124(2):370-7.
163 Adaptive homeostasis of the vitamin D-vitamin D nuclear receptor axis in 8-methoxypsoralen-induced hepatotoxicity. Toxicol Appl Pharmacol. 2019 Jan 1;362:150-158. doi: 10.1016/j.taap.2018.11.002. Epub 2018 Nov 10.
164 Arsenite and cadmium promote the development of mammary tumors. Carcinogenesis. 2020 Jul 14;41(7):1005-1014. doi: 10.1093/carcin/bgz176.
165 Time series analysis of oxidative stress response patterns in HepG2: a toxicogenomics approach. Toxicology. 2013 Apr 5;306:24-34.
166 Farnesoid X receptor induces murine scavenger receptor Class B type I via intron binding. PLoS One. 2012;7(4):e35895. doi: 10.1371/journal.pone.0035895. Epub 2012 Apr 23.
167 The methyl transferase PRMT1 functions as co-activator of farnesoid X receptor (FXR)/9-cis retinoid X receptor and regulates transcription of FXR responsive genes. Mol Pharmacol. 2005 Aug;68(2):551-8. doi: 10.1124/mol.105.012104. Epub 2005 May 23.
168 Keratinocyte-derived IL-36gama plays a role in hydroquinone-induced chemical leukoderma through inhibition of melanogenesis in human epidermal melanocytes. Arch Toxicol. 2019 Aug;93(8):2307-2320.
169 Effects of 1alpha,25 dihydroxyvitamin D3 and testosterone on miRNA and mRNA expression in LNCaP cells. Mol Cancer. 2011 May 18;10:58.
170 Integrating multiple omics to unravel mechanisms of Cyclosporin A induced hepatotoxicity in vitro. Toxicol In Vitro. 2015 Apr;29(3):489-501.
171 ERE-independent ERalpha target genes differentially expressed in human breast tumors. Mol Cell Endocrinol. 2005 Dec 21;245(1-2):53-9. doi: 10.1016/j.mce.2005.10.003. Epub 2005 Nov 17.
172 Phenotypic characterization of retinoic acid differentiated SH-SY5Y cells by transcriptional profiling. PLoS One. 2013 May 28;8(5):e63862.
173 Docosahexaenoic acid regulates gene expression in HUVEC cells treated with polycyclic aromatic hydrocarbons. Toxicol Lett. 2015 Jul 16;236(2):75-81.
174 Etoposide induces necrosis through p53-mediated antiapoptosis in human kidney proximal tubule cells. Toxicol Sci. 2015 Nov;148(1):204-19.
175 Conjugated linoleic acid, unlike other unsaturated fatty acids, strongly induces glutathione synthesis without any lipoperoxidation. Br J Nutr. 2006 Nov;96(5):811-9.
176 COX-2 and PPAR-gama confer cannabidiol-induced apoptosis of human lung cancer cells. Mol Cancer Ther. 2013 Jan;12(1):69-82.
177 Mitochondrial involvement in schizophrenia and other functional psychoses. Neurochem Res. 1996 Sep;21(9):995-1004.
178 Stimulation of cyclooxygenase-2 expression by bone-derived transforming growth factor-beta enhances bone metastases in breast cancer. Cancer Res. 2006 Feb 15;66(4):2067-73.
179 An in vitro coculture system of human peripheral blood mononuclear cells with hepatocellular carcinoma-derived cells for predicting drug-induced liver injury. Arch Toxicol. 2021 Jan;95(1):149-168. doi: 10.1007/s00204-020-02882-4. Epub 2020 Aug 20.
180 A2E selectively induces cox-2 in ARPE-19 and human neural cells. Curr Eye Res. 2006 Mar;31(3):259-63.
181 Pharmacodynamic of cyclooxygenase inhibitors in humans. Prostaglandins Other Lipid Mediat. 2007 Jan;82(1-4):85-94.
182 Cannabidiol Modulates the Immunophenotype and Inhibits the Activation of the Inflammasome in Human Gingival Mesenchymal Stem Cells. Front Physiol. 2016 Nov 24;7:559. doi: 10.3389/fphys.2016.00559. eCollection 2016.
183 Diesel exhaust particulate-induced activation of Stat3 requires activities of EGFR and Src in airway epithelial cells. Am J Physiol Lung Cell Mol Physiol. 2007 Feb;292(2):L422-9. doi: 10.1152/ajplung.00204.2006. Epub 2006 Oct 6.
184 Physapubescin B enhances the sensitivity of gastric cancer cells to trametinib by inhibiting the STAT3 signaling pathway. Toxicol Appl Pharmacol. 2020 Dec 1;408:115273. doi: 10.1016/j.taap.2020.115273. Epub 2020 Oct 6.
185 Sulindac induces apoptosis and inhibits tumor growth in vivo in head and neck squamous cell carcinoma. Neoplasia. 2007 Mar;9(3):192-9. doi: 10.1593/neo.06781.
186 Simvastatin acts as an inhibitor of interferon gamma-induced cycloxygenase-2 expression in human THP-1 cells, but not in murine RAW264.7 cells. Biocell. 2009 Aug;33(2):107-14.
187 Therapeutic potential of cladribine in combination with STAT3 inhibitor against multiple myeloma. BMC Cancer. 2011 Jun 16;11:255. doi: 10.1186/1471-2407-11-255.
188 Quercetin exerts anti-melanoma activities and inhibits STAT3 signaling. Biochem Pharmacol. 2014 Feb 1;87(3):424-34. doi: 10.1016/j.bcp.2013.11.008. Epub 2013 Nov 23.
189 Aromatase inhibition: translation into a successful therapeutic approach. Clin Cancer Res. 2005 Apr 15;11(8):2809-21. doi: 10.1158/1078-0432.CCR-04-2187.
190 Cannabidiol (CBD) but not tetrahydrocannabinol (THC) dysregulate in vitro decidualization of human endometrial stromal cells by disruption of estrogen signaling. Reprod Toxicol. 2020 Apr;93:75-82. doi: 10.1016/j.reprotox.2020.01.003. Epub 2020 Jan 14.
191 Synthesis and evaluation of (pyridylmethylene)tetrahydronaphthalenes/-indanes and structurally modified derivatives: potent and selective inhibitors of aldosterone synthase. J Med Chem. 2005 Mar 10;48(5):1563-75.
192 Comparative assessment of the inhibition of recombinant human CYP19 (aromatase) by azoles used in agriculture and as drugs for humans. Endocr Res. 2004 Aug;30(3):387-94.
193 Estrogen synthesis in human colon cancer epithelial cells. J Steroid Biochem Mol Biol. 1999 Dec 31;71(5-6):223-30.
194 Human embryonic stem cell-derived test systems for developmental neurotoxicity: a transcriptomics approach. Arch Toxicol. 2013 Jan;87(1):123-43.
195 Physiological and toxicological transcriptome changes in HepG2 cells exposed to copper. Physiol Genomics. 2009 Aug 7;38(3):386-401.
196 Gene expression analysis of precision-cut human liver slices indicates stable expression of ADME-Tox related genes. Toxicol Appl Pharmacol. 2011 May 15;253(1):57-69.
197 Air pollution and DNA methylation alterations in lung cancer: A systematic and comparative study. Oncotarget. 2017 Jan 3;8(1):1369-1391. doi: 10.18632/oncotarget.13622.
198 Cell-based two-dimensional morphological assessment system to predict cancer drug-induced cardiotoxicity using human induced pluripotent stem cell-derived cardiomyocytes. Toxicol Appl Pharmacol. 2019 Nov 15;383:114761. doi: 10.1016/j.taap.2019.114761. Epub 2019 Sep 15.
199 Endoplasmic reticulum stress impairs insulin signaling through mitochondrial damage in SH-SY5Y cells. Neurosignals. 2012;20(4):265-80.
200 Glyphosate-based herbicides at low doses affect canonical pathways in estrogen positive and negative breast cancer cell lines. PLoS One. 2019 Jul 11;14(7):e0219610. doi: 10.1371/journal.pone.0219610. eCollection 2019.
201 Functional gene expression profile underlying methotrexate-induced senescence in human colon cancer cells. Tumour Biol. 2011 Oct;32(5):965-76.
202 Flavones and flavonols exert cytotoxic effects on a human oesophageal adenocarcinoma cell line (OE33) by causing G2/M arrest and inducing apoptosis. Food Chem Toxicol. 2008 Jun;46(6):2042-53. doi: 10.1016/j.fct.2008.01.049. Epub 2008 Feb 7.
203 Endoplasmic reticulum stress contributes to arsenic trioxide-induced intrinsic apoptosis in human umbilical and bone marrow mesenchymal stem cells. Environ Toxicol. 2016 Mar;31(3):314-28.
204 THC exposure of human iPSC neurons impacts genes associated with neuropsychiatric disorders. Transl Psychiatry. 2018 Apr 25;8(1):89. doi: 10.1038/s41398-018-0137-3.
205 Cannabidiol promotes apoptosis via regulation of XIAP/Smac in gastric cancer. Cell Death Dis. 2019 Nov 7;10(11):846. doi: 10.1038/s41419-019-2001-7.
206 Asbestos-induced alveolar epithelial cell apoptosis. The role of endoplasmic reticulum stress response. Am J Respir Cell Mol Biol. 2013 Dec;49(6):892-901. doi: 10.1165/rcmb.2013-0053OC.
207 Drug-induced hepatic steatosis in absence of severe mitochondrial dysfunction in HepaRG cells: proof of multiple mechanism-based toxicity. Cell Biol Toxicol. 2021 Apr;37(2):151-175. doi: 10.1007/s10565-020-09537-1. Epub 2020 Jun 14.
208 Quercetin enhances apoptotic effect of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in ovarian cancer cells through reactive oxygen species (ROS) mediated CCAAT enhancer-binding protein homologous protein (CHOP)-death receptor 5 pathway. Cancer Sci. 2014 May;105(5):520-7. doi: 10.1111/cas.12395. Epub 2014 Apr 11.
209 Pyrazinamide-induced hepatotoxicity is alleviated by 4-PBA via inhibition of the PERK-eIF2-ATF4-CHOP pathway. Toxicology. 2017 Mar 1;378:65-75. doi: 10.1016/j.tox.2017.01.002. Epub 2017 Jan 4.
210 NGBR is required to ameliorate type 2 diabetes in mice by enhancing insulin sensitivity. J Biol Chem. 2021 Jan-Jun;296:100624. doi: 10.1016/j.jbc.2021.100624. Epub 2021 Apr 2.
211 Arsenic trioxide initiates ER stress responses, perturbs calcium signalling and promotes apoptosis in human lens epithelial cells. Exp Eye Res. 2007 Dec;85(6):825-35. doi: 10.1016/j.exer.2007.08.018. Epub 2007 Aug 29.
212 Novel functional view of the crocidolite asbestos-treated A549 human lung epithelial transcriptome reveals an intricate network of pathways with opposing functions. BMC Genomics. 2008 Aug 7;9:376.
213 Methotrexate modulates folate phenotype and inflammatory profile in EA.hy 926 cells. Eur J Pharmacol. 2014 Jun 5;732:60-7.
214 Chronic occupational exposure to arsenic induces carcinogenic gene signaling networks and neoplastic transformation in human lung epithelial cells. Toxicol Appl Pharmacol. 2012 Jun 1;261(2):204-16.
215 Polyunsaturated fatty acids synergize with lipid droplet binding thalidomide analogs to induce oxidative stress in cancer cells. Lipids Health Dis. 2010 Jun 2;9:56. doi: 10.1186/1476-511X-9-56.
216 Single-cell Transcriptome Mapping Identifies Common and Cell-type Specific Genes Affected by Acute Delta9-tetrahydrocannabinol in Humans. Sci Rep. 2020 Feb 26;10(1):3450. doi: 10.1038/s41598-020-59827-1.
217 Transcriptomics hit the target: monitoring of ligand-activated and stress response pathways for chemical testing. Toxicol In Vitro. 2015 Dec 25;30(1 Pt A):7-18.
218 Utilization of CDKN1A/p21 gene for class discrimination of DNA damage-induced clastogenicity. Toxicology. 2014 Jan 6;315:8-16. doi: 10.1016/j.tox.2013.10.009. Epub 2013 Nov 6.
219 Inflammation in methotrexate-induced pulmonary toxicity occurs via the p38 MAPK pathway. Toxicology. 2009 Feb 27;256(3):183-90. doi: 10.1016/j.tox.2008.11.016. Epub 2008 Nov 28.
220 The exosome-like vesicles derived from androgen exposed-prostate stromal cells promote epithelial cells proliferation and epithelial-mesenchymal transition. Toxicol Appl Pharmacol. 2021 Jan 15;411:115384. doi: 10.1016/j.taap.2020.115384. Epub 2020 Dec 25.
221 Endoplasmic reticulum stress and MAPK signaling pathway activation underlie leflunomide-induced toxicity in HepG2 Cells. Toxicology. 2017 Dec 1;392:11-21.
222 Prenatal arsenic exposure and the epigenome: identifying sites of 5-methylcytosine alterations that predict functional changes in gene expression in newborn cord blood and subsequent birth outcomes. Toxicol Sci. 2015 Jan;143(1):97-106. doi: 10.1093/toxsci/kfu210. Epub 2014 Oct 10.
223 Expression profile analysis of human peripheral blood mononuclear cells in response to aspirin. Arch Immunol Ther Exp (Warsz). 2005 Mar-Apr;53(2):151-8.
224 Characterization of formaldehyde's genotoxic mode of action by gene expression analysis in TK6 cells. Arch Toxicol. 2013 Nov;87(11):1999-2012.
225 The proapoptotic effect of zoledronic acid is independent of either the bone microenvironment or the intrinsic resistance to bortezomib of myeloma cells and is enhanced by the combination with arsenic trioxide. Exp Hematol. 2011 Jan;39(1):55-65.
226 Drug-induced endoplasmic reticulum and oxidative stress responses independently sensitize toward TNF-mediated hepatotoxicity. Toxicol Sci. 2014 Jul;140(1):144-59. doi: 10.1093/toxsci/kfu072. Epub 2014 Apr 20.
227 Cysteine mapping in conformationally distinct kinase nucleotide binding sites: application to the design of selective covalent inhibitors. J Med Chem. 2011 Mar 10;54(5):1347-55. doi: 10.1021/jm101396q. Epub 2011 Feb 15.
228 Dasatinib (BMS-354825) selectively induces apoptosis in lung cancer cells dependent on epidermal growth factor receptor signaling for survival. Cancer Res. 2006 Jun 1;66(11):5542-8. doi: 10.1158/0008-5472.CAN-05-4620.
229 Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N Engl J Med. 2004 May 20;350(21):2129-39. doi: 10.1056/NEJMoa040938. Epub 2004 Apr 29.
230 The dual ErbB1/ErbB2 inhibitor, lapatinib (GW572016), cooperates with tamoxifen to inhibit both cell proliferation- and estrogen-dependent gene expression in antiestrogen-resistant breast cancer. Cancer Res. 2005 Jan 1;65(1):18-25.
231 A fine-needle aspirate-based vulnerability assay identifies polo-like kinase 1 as a mediator of gemcitabine resistance in pancreatic cancer. Mol Cancer Ther. 2010 Feb;9(2):311-8. doi: 10.1158/1535-7163.MCT-09-0693. Epub 2010 Jan 26.
232 Prediction of chemosensitivity using multigene analysis in head and neck squamous cell carcinoma. Oncology. 2007;73(1-2):104-11. doi: 10.1159/000120998. Epub 2008 Mar 13.
233 Minimal peroxide exposure of neuronal cells induces multifaceted adaptive responses. PLoS One. 2010 Dec 17;5(12):e14352. doi: 10.1371/journal.pone.0014352.
234 Inhibition of invasion and induction of apoptosis by selenium in human malignant brain tumour cells in vitro. Int J Oncol. 2007 May;30(5):1263-71.
235 Ligand-dependent activation of the epidermal growth factor receptor by secondary bile acids in polarizing colon cancer cells. Surgery. 2005 Sep;138(3):415-21. doi: 10.1016/j.surg.2005.06.030.
236 Quercetin inhibits invasion, migration and signalling molecules involved in cell survival and proliferation of prostate cancer cell line (PC-3). Cell Biochem Funct. 2011 Mar;29(2):87-95. doi: 10.1002/cbf.1725. Epub 2011 Feb 9.
237 Essential role of cell cycle regulatory genes p21 and p27 expression in inhibition of breast cancer cells by arsenic trioxide. Med Oncol. 2011 Dec;28(4):1225-54.
238 Cannabidiol Activates Neuronal Precursor Genes in Human Gingival Mesenchymal Stromal Cells. J Cell Biochem. 2017 Jun;118(6):1531-1546. doi: 10.1002/jcb.25815. Epub 2016 Dec 29.
239 Selection of drugs to test the specificity of the Tg.AC assay by screening for induction of the gadd153 promoter in vitro. Toxicol Sci. 2003 Aug;74(2):260-70. doi: 10.1093/toxsci/kfg113. Epub 2003 May 2.
240 Estrogen regulation in human breast cancer cells of new downstream gene targets involved in estrogen metabolism, cell proliferation and cell transformation. J Mol Endocrinol. 2004 Apr;32(2):397-414.
241 Microarray analysis of H2O2-, HNE-, or tBH-treated ARPE-19 cells. Free Radic Biol Med. 2002 Nov 15;33(10):1419-32.
242 Methotrexate induces production of IL-1 and IL-6 in the monocytic cell line U937. Arthritis Res Ther. 2014 Jan 20;16(1):R17. doi: 10.1186/ar4444.
243 Simvastatin inhibits NOR-1 expression induced by hyperlipemia by interfering with CREB activation. Cardiovasc Res. 2005 Aug 1;67(2):333-41. doi: 10.1016/j.cardiores.2005.03.016. Epub 2005 Apr 21.
244 The G protein-coupled receptor GPR30 mediates c-fos up-regulation by 17beta-estradiol and phytoestrogens in breast cancer cells. J Biol Chem. 2004 Jun 25;279(26):27008-16. doi: 10.1074/jbc.M403588200. Epub 2004 Apr 16.
245 Fluoxetine inhibits the extracellular signal regulated kinase pathway and suppresses growth of cancer cells. Cancer Biol Ther. 2008 Oct;7(10):1685-93. doi: 10.4161/cbt.7.10.6664. Epub 2008 Oct 22.
246 Acetaminophen-induced proliferation of estrogen-responsive breast cancer cells is associated with increases in c-myc RNA expression and NF-kappaB activity. Toxicol Sci. 2002 Apr;66(2):233-43. doi: 10.1093/toxsci/66.2.233.
247 ZD1839 induces p15INK4b and causes G1 arrest by inhibiting the mitogen-activated protein kinase/extracellular signal-regulated kinase pathway. Mol Cancer Ther. 2007 May;6(5):1579-87. doi: 10.1158/1535-7163.MCT-06-0814.
248 Arsenic suppresses gene expression in promyelocytic leukemia cells partly through Sp1 oxidation. Blood. 2005 Jul 1;106(1):304-10.
249 Selenite and selenomethionine promote HL-60 cell cycle progression. J Nutr. 2002 Apr;132(4):674-9. doi: 10.1093/jn/132.4.674.
250 Ribavirin augments doxorubicin's efficacy in human hepatocellular carcinoma through inhibiting doxorubicin-induced eIF4E activation. J Biochem Mol Toxicol. 2018 Jan;32(1). doi: 10.1002/jbt.22007. Epub 2017 Nov 7.
251 Combination small molecule MEK and PI3K inhibition enhances uveal melanoma cell death in a mutant GNAQ- and GNA11-dependent manner. Clin Cancer Res. 2012 Aug 15;18(16):4345-55. doi: 10.1158/1078-0432.CCR-11-3227. Epub 2012 Jun 25.
252 Novel detection and differential utilization of a c-myc transcriptional block in colon cancer chemoprevention. Cancer Res. 2002 Nov 1;62(21):6006-10.
253 Response rate of fibrosarcoma cells to cytotoxic drugs on the expression level correlates to the therapeutic response rate of fibrosarcomas and is mediated by regulation of apoptotic pathways. BMC Cancer. 2005 Jul 7;5:74. doi: 10.1186/1471-2407-5-74.
254 Indomethacin and juglone inhibit inflammatory molecules to induce apoptosis in colon cancer cells. J Biochem Mol Toxicol. 2020 Feb;34(2):e22433. doi: 10.1002/jbt.22433. Epub 2020 Jan 9.
255 A cell impedance-based real-time in vitro assay to assess the toxicity of amphotericin B formulations. Toxicol Appl Pharmacol. 2017 Nov 1;334:18-23. doi: 10.1016/j.taap.2017.08.017. Epub 2017 Sep 1.
256 CBD Promotes Oral Ulcer Healing via Inhibiting CMPK2-Mediated Inflammasome. J Dent Res. 2022 Feb;101(2):206-215. doi: 10.1177/00220345211024528. Epub 2021 Jul 16.
257 Anti-inflammatory effects of the GABA(B) receptor agonist baclofen in allergic contact dermatitis. Exp Dermatol. 2010 Jul 1;19(7):661-6. doi: 10.1111/j.1600-0625.2010.01076.x. Epub 2010 Feb 25.
258 Frankincense myrrh attenuates hepatocellular carcinoma by regulating tumor blood vessel development through multiple epidermal growth factor receptor-mediated signaling pathways. World J Gastrointest Oncol. 2022 Feb 15;14(2):450-477. doi: 10.4251/wjgo.v14.i2.450.
259 Sulfasalazine unveils a contact-independent HSV-TK/ganciclovir gene therapy bystander effect in malignant gliomas. Int J Oncol. 2007 Jan;30(1):283-90.
260 Regulatory role of nitric oxide on monocyte-derived dendritic cell functions. J Interferon Cytokine Res. 2003 Aug;23(8):423-31. doi: 10.1089/107999003322277838.
261 Integrative "-Omics" analysis in primary human hepatocytes unravels persistent mechanisms of cyclosporine A-induced cholestasis. Chem Res Toxicol. 2016 Dec 19;29(12):2164-2174.
262 cDNA microarray analysis of isogenic paclitaxel- and doxorubicin-resistant breast tumor cell lines reveals distinct drug-specific genetic signatures of resistance. Breast Cancer Res Treat. 2006 Mar;96(1):17-39. doi: 10.1007/s10549-005-9026-6. Epub 2005 Dec 2.
263 Ethyl carbamate induces cell death through its effects on multiple metabolic pathways. Chem Biol Interact. 2017 Nov 1;277:21-32.
264 A protein-coated magnetic beads as a tool for the rapid drug-protein binding study. J Pharm Biomed Anal. 2010 Jul 8;52(3):420-4. doi: 10.1016/j.jpba.2009.06.023. Epub 2009 Jun 18.
265 The three recombinant domains of human serum albumin. Structural characterization and ligand binding properties. J Biol Chem. 1999 Oct 8;274(41):29303-10. doi: 10.1074/jbc.274.41.29303.
266 Low-expressional IGF1 mediated methimazole-induced liver developmental toxicity in fetal mice. Toxicology. 2018 Sep 1;408:70-79. doi: 10.1016/j.tox.2018.07.004. Epub 2018 Jul 7.
267 Use of peak decay analysis and affinity microcolumns containing silica monoliths for rapid determination of drug-protein dissociation rates. J Chromatogr A. 2011 Apr 15;1218(15):2072-8. doi: 10.1016/j.chroma.2010.09.070. Epub 2010 Oct 16.
268 [Colchicine in chronic liver disease of alcoholic etiology. Double-blind, randomized study of its effects on blood levels of plasma proteins and clinical course in patients]. Rev Assoc Med Bras (1992). 1995 May-Jun;41(3):207-12.
269 Editor's Highlight: Modeling Compound-Induced Fibrogenesis In Vitro Using Three-Dimensional Bioprinted Human Liver Tissues. Toxicol Sci. 2016 Dec;154(2):354-367. doi: 10.1093/toxsci/kfw169. Epub 2016 Sep 7.
270 Covalent binding of the flavonoid quercetin to human serum albumin. J Agric Food Chem. 2005 May 18;53(10):4194-7. doi: 10.1021/jf050061m.
271 [Unstable stenocardia: indicators of platelet activity and the effect of verapamil]. Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR. 1987;10(2):33-9.
272 Evaluation of platelet activation in depressed patients with ischemic heart disease after paroxetine or nortriptyline treatment. J Clin Psychopharmacol. 2000 Apr;20(2):137-40. doi: 10.1097/00004714-200004000-00004.
273 Global effects of inorganic arsenic on gene expression profile in human macrophages. Mol Immunol. 2009 Feb;46(4):649-56.
274 Platelet morphology and plasma indices of platelet activation in essential hypertension: effects of amlodipine-based antihypertensive therapy. Ann Med. 2004;36(7):552-7. doi: 10.1080/07853890410017386.
275 Interleukin-19 as a translational indicator of renal injury. Arch Toxicol. 2015 Jan;89(1):101-6.
276 Cocaine activates platelets and increases the formation of circulating platelet containing microaggregates in humans. Heart. 2000 Jun;83(6):688-95. doi: 10.1136/heart.83.6.688.
277 Arsenic exposure from drinking water is associated with decreased gene expression and increased DNA methylation in peripheral blood. Toxicol Appl Pharmacol. 2017 Apr 15;321:57-66. doi: 10.1016/j.taap.2017.02.019. Epub 2017 Feb 24.
278 Non-nutritional sweeteners effects on endothelial vascular function. Toxicol In Vitro. 2020 Feb;62:104694. doi: 10.1016/j.tiv.2019.104694. Epub 2019 Oct 23.
279 Design principles of concentration-dependent transcriptome deviations in drug-exposed differentiating stem cells. Chem Res Toxicol. 2014 Mar 17;27(3):408-20.
280 Prenatal arsenic exposure and shifts in the newborn proteome: interindividual differences in tumor necrosis factor (TNF)-responsive signaling. Toxicol Sci. 2014 Jun;139(2):328-37. doi: 10.1093/toxsci/kfu053. Epub 2014 Mar 27.
281 Bringing in vitro analysis closer to in vivo: studying doxorubicin toxicity and associated mechanisms in 3D human microtissues with PBPK-based dose modelling. Toxicol Lett. 2018 Sep 15;294:184-192.
282 Carotid endarterectomy in patients with heparin-induced platelet activation: comparative efficacy of aspirin and iloprost (ZK36374). J Vasc Surg. 1987 May;5(5):693-701.
283 Arsenite stress down-regulates phosphorylation and 14-3-3 binding of leucine-rich repeat kinase 2 (LRRK2), promoting self-association and cellular redistribution. J Biol Chem. 2014 Aug 1;289(31):21386-400. doi: 10.1074/jbc.M113.528463. Epub 2014 Jun 18.
284 Troglitazone suppresses cell growth of KU812 cells independently of PPARgamma. Eur J Pharmacol. 2002 Feb 1;436(1-2):7-13. doi: 10.1016/s0014-2999(01)01577-1.
285 D-Penicillamine targets metastatic melanoma cells with induction of the unfolded protein response (UPR) and Noxa (PMAIP1)-dependent mitochondrial apoptosis. Apoptosis. 2012 Oct;17(10):1079-94.
286 Retinoic acid-induced downmodulation of telomerase activity in human cancer cells. Exp Mol Pathol. 2005 Oct;79(2):108-17.
287 Lon protease and eiF2 are involved in acute, but not prolonged, antiretroviral induced stress response in HepG2 cells. Chem Biol Interact. 2016 May 25;252:82-6. doi: 10.1016/j.cbi.2016.03.021. Epub 2016 Apr 1.
288 Glucosamine-induced endoplasmic reticulum stress attenuates apolipoprotein B100 synthesis via PERK signaling. J Lipid Res. 2009 Sep;50(9):1814-23. doi: 10.1194/jlr.M800343-JLR200. Epub 2009 Apr 21.
289 Bupropion, an atypical antidepressant, induces endoplasmic reticulum stress and caspase-dependent cytotoxicity in SH-SY5Y cells. Toxicology. 2011 Jul 11;285(1-2):1-7. doi: 10.1016/j.tox.2011.02.006. Epub 2011 Feb 24.
290 High-dose mitoxantrone induces programmed cell death or apoptosis in human myeloid leukemia cells. Blood. 1993 Nov 15;82(10):3133-40.
291 Gene expression data from acetaminophen-induced toxicity in human hepatic in vitro systems and clinical liver samples. Data Brief. 2016 Mar 26;7:1052-1057. doi: 10.1016/j.dib.2016.03.069. eCollection 2016 Jun.
292 Inhibition of autophagic flux differently modulates cannabidiol-induced death in 2D and 3D glioblastoma cell cultures. Sci Rep. 2020 Feb 14;10(1):2687. doi: 10.1038/s41598-020-59468-4.
293 Nitrogen mustard prevents transport of Fra-1 into the nucleus to promote c-Fos- and FosB-dependent IL-8 induction in injured mouse epidermis. Toxicol Lett. 2020 Feb 1;319:256-263. doi: 10.1016/j.toxlet.2019.10.006. Epub 2019 Oct 19.
294 Gene expression profiles with activation of the estrogen receptor alpha-selective estrogen receptor modulator complex in breast cancer cells expressing wild-type estrogen receptor. Cancer Res. 2002 Aug 1;62(15):4419-26.
295 Oxidative stress modulates theophylline effects on steroid responsiveness. Biochem Biophys Res Commun. 2008 Dec 19;377(3):797-802.
296 Nocodazole-induced p53-dependent c-Jun N-terminal kinase activation reduces apoptosis in human colon carcinoma HCT116 cells. J Biol Chem. 2002 Nov 15;277(46):43648-58. doi: 10.1074/jbc.M203214200. Epub 2002 Sep 6.
297 [Regulation mechanism of autophagy-related protein LC3 by c-Jun in methotrexate resistant human choriocarcinoma JEG-3 cells]. Zhonghua Fu Chan Ke Za Zhi. 2014 Jul;49(7):531-5.
298 Simvastatin suppresses tissue factor expression and increases fibrinolytic activity in tumor necrosis factor-alpha-activated human peritoneal mesothelial cells. Kidney Int. 2003 Jun;63(6):2065-74. doi: 10.1046/j.1523-1755.2003.t01-2-00004.x.
299 Moving toward integrating gene expression profiling into high-throughput testing: a gene expression biomarker accurately predicts estrogen receptor alpha modulation in a microarray compendium. Toxicol Sci. 2016 May;151(1):88-103.
300 Activation of PPAR and inhibition of cell proliferation reduces key proteins associated with the basal subtype of bladder cancer in As3+-transformed UROtsa cells. PLoS One. 2020 Aug 21;15(8):e0237976. doi: 10.1371/journal.pone.0237976. eCollection 2020.
301 Constitutive gene expression predisposes morphogen-mediated cell fate responses of NT2/D1 and 27X-1 human embryonal carcinoma cells. Stem Cells. 2007 Mar;25(3):771-8. doi: 10.1634/stemcells.2006-0271. Epub 2006 Nov 30.
302 Impact of selective serotonin reuptake inhibitors on neural crest stem cell formation. Toxicol Lett. 2017 Nov 5;281:20-25. doi: 10.1016/j.toxlet.2017.08.012. Epub 2017 Aug 24.
303 Real-time PCR analysis of the apoptosis related genes in ATRA treated APL t(15;17) patients. Exp Mol Med. 2003 Oct 31;35(5):454-9. doi: 10.1038/emm.2003.59.
304 Epigenetic activation of O-linked -N-acetylglucosamine transferase overrides the differentiation blockage in acute leukemia. EBioMedicine. 2020 Apr;54:102678. doi: 10.1016/j.ebiom.2020.102678. Epub 2020 Apr 6.
305 Histamine downregulates CD14 expression via H2 receptors on human monocytes. Clin Immunol. 2003 Sep;108(3):274-81. doi: 10.1016/s1521-6616(03)00140-2.
306 The anti-proliferative effect of calcitriol on HL-60 cells is neutralized by uraemic biological fluids. Nephrol Dial Transplant. 2001 Feb;16(2):246-52. doi: 10.1093/ndt/16.2.246.
307 Integrin expression on monocytes and lymphocytes in unstable angina short term effects of atorvastatin. Rom J Intern Med. 2007;45(2):193-9.
308 Serious carbamazepine-induced hypersensitivity reactions associated with the HSP70 gene cluster. Pharmacogenet Genomics. 2006 Apr;16(4):287-96. doi: 10.1097/01.fpc.0000189800.88596.7a.
309 Reactive metabolite of gefitinib activates inflammasomes: implications for gefitinib-induced idiosyncratic reaction. J Toxicol Sci. 2020;45(11):673-680. doi: 10.2131/jts.45.673.
310 Gene expression after treatment with hydrogen peroxide, menadione, or t-butyl hydroperoxide in breast cancer cells. Cancer Res. 2002 Nov 1;62(21):6246-54.
311 Consequences of the natural retinoid/retinoid X receptor ligands action in human breast cancer MDA-MB-231 cell line: Focus on functional proteomics. Toxicol Lett. 2017 Nov 5;281:26-34. doi: 10.1016/j.toxlet.2017.09.001. Epub 2017 Sep 5.
312 Increased sensitivity for troglitazone-induced cytotoxicity using a human in vitro co-culture model. Toxicol In Vitro. 2009 Oct;23(7):1387-95.
313 4.8% sevoflurane induces activation of autophagy in human neuroblastoma SH-SY5Y cells by the AMPK/mTOR signaling pathway. Neurotoxicology. 2022 May;90:256-264. doi: 10.1016/j.neuro.2022.04.008. Epub 2022 Apr 23.
314 Enhanced chemotherapeutic efficacy of docetaxel in human lung cancer cell line via GLUT1 inhibitor. J Biochem Mol Toxicol. 2023 Jun;37(6):e23348. doi: 10.1002/jbt.23348. Epub 2023 Mar 31.
315 Breast cancer cells response to the antineoplastic agents cisplatin, carboplatin, and doxorubicin at the mRNA expression levels of distinct apoptosis-related genes, including the new member, BCL2L12. Ann N Y Acad Sci. 2007 Jan;1095:35-44. doi: 10.1196/annals.1397.005.
316 Extracellular signal-regulated kinase activation and Bcl-2 downregulation mediate apoptosis after gemcitabine treatment partly via a p53-independent pathway. Eur J Pharmacol. 2004 Oct 19;502(3):169-83. doi: 10.1016/j.ejphar.2004.09.006.
317 Verapamil potentiates anti-glioblastoma efficacy of temozolomide by modulating apoptotic signaling. Toxicol In Vitro. 2018 Oct;52:306-313. doi: 10.1016/j.tiv.2018.07.001. Epub 2018 Jul 9.
318 Inhibition of caspase-dependent mitochondrial permeability transition protects airway epithelial cells against mustard-induced apoptosis. Apoptosis. 2006 Sep;11(9):1545-59. doi: 10.1007/s10495-006-8764-1.
319 -Carotene Induces Apoptosis in Human Esophageal Squamous Cell Carcinoma Cell Lines via the Cav-1/AKT/NF-B Signaling Pathway. J Biochem Mol Toxicol. 2016 Mar;30(3):148-57. doi: 10.1002/jbt.21773. Epub 2016 Jan 6.
320 Mechanisms of thymidine kinase/ganciclovir and cytosine deaminase/ 5-fluorocytosine suicide gene therapy-induced cell death in glioma cells. Oncogene. 2005 Feb 10;24(7):1231-43. doi: 10.1038/sj.onc.1208290.
321 Cannabidiol Modulates the Expression of Alzheimer's Disease-Related Genes in Mesenchymal Stem Cells. Int J Mol Sci. 2016 Dec 23;18(1):26. doi: 10.3390/ijms18010026.
322 Identification of biomarkers for the initiation of apoptosis in human preneoplastic colonocytes by proteome analysis. Int J Cancer. 2004 Mar 20;109(2):220-9. doi: 10.1002/ijc.11692.
323 Pharmacogenomic analysis of acute promyelocytic leukemia cells highlights CYP26 cytochrome metabolism in differential all-trans retinoic acid sensitivity. Blood. 2007 May 15;109(10):4450-60.
324 Proteomic and functional analyses reveal a dual molecular mechanism underlying arsenic-induced apoptosis in human multiple myeloma cells. J Proteome Res. 2009 Jun;8(6):3006-19.
325 Gene expression changes in human small airway epithelial cells exposed to Delta9-tetrahydrocannabinol. Toxicol Lett. 2005 Aug 14;158(2):95-107.
326 Indomethacin and ibuprofen induce Hsc70 nuclear localization and activation of the heat shock response in HeLa cells. Biochem Biophys Res Commun. 2004 Jan 23;313(4):863-70. doi: 10.1016/j.bbrc.2003.12.018.
327 Combination of arsenic trioxide and Dasatinib: a new strategy to treat Philadelphia chromosome-positive acute lymphoblastic leukaemia. J Cell Mol Med. 2018 Mar;22(3):1614-1626.
328 p38 MAPK/PP2Ac/TTP pathway on the connection of TNF- and caspases activation on hydroquinone-induced apoptosis. Carcinogenesis. 2013 Apr;34(4):818-27. doi: 10.1093/carcin/bgs409. Epub 2013 Jan 3.
329 Sevoflurane-mediated activation of p38-mitogen-activated stresskinase is independent of apoptosis in Jurkat T-cells. Anesth Analg. 2008 Apr;106(4):1150-60, table of contents. doi: 10.1213/ane.0b013e3181683d37.
330 Identification of biomarkers and outcomes of endocrine disruption in human ovarian cortex using In Vitro Models. Toxicology. 2023 Feb;485:153425. doi: 10.1016/j.tox.2023.153425. Epub 2023 Jan 5.
331 Hemostatic abnormalities associated with acute promyelocytic leukemia and corrective effects of all-trans-retinoic acid or arsenic trioxide treatment. Chin Med J (Engl). 2000 Mar;113(3):236-40.
332 Lack of uniform platelet activation in patients after ischemic stroke and choice of antiplatelet therapy. Thromb Res. 2004;113(3-4):197-204. doi: 10.1016/j.thromres.2004.03.002.
333 Magnitude and time course of platelet inhibition with Aggrenox and Aspirin in patients after ischemic stroke: the AGgrenox versus Aspirin Therapy Evaluation (AGATE) trial. Eur J Pharmacol. 2004 Sep 24;499(3):315-24. doi: 10.1016/j.ejphar.2004.07.114.
334 Effects of histamine 2 receptor antagonists on endothelial-neutrophil adhesion and surface expression of endothelial adhesion molecules induced by high glucose levels. J Diabetes Complications. 2007 Jan-Feb;21(1):50-5. doi: 10.1016/j.jdiacomp.2006.02.002.
335 Reduced plaque formation induced by rosiglitazone in an STZ-diabetes mouse model of atherosclerosis is associated with downregulation of adhesion molecules. Atherosclerosis. 2008 Jul;199(1):55-64. doi: 10.1016/j.atherosclerosis.2007.10.038. Epub 2008 Feb 21.
336 A flow cytometric assay of platelet activation marker P-selectin (CD62P) distinguishes heparin-induced thrombocytopenia (HIT) from HIT with thrombosis (HITT). Thromb Haemost. 1999 Oct;82(4):1255-9.
337 Low dosage of arsenic trioxide (As(2)O(3)) inhibits angiogenesis in epithelial ovarian cancer without cell apoptosis. J Biol Inorg Chem. 2018 Aug;23(6):939-947. doi: 10.1007/s00775-018-1595-z. Epub 2018 Jul 16.
338 Thalidomide suppresses angiogenesis and immune evasion via lncRNA FGD5-AS1/miR-454-3p/ZEB1 axis-mediated VEGFA expression and PD-1/PD-L1 checkpoint in NSCLC. Chem Biol Interact. 2021 Nov 1;349:109652. doi: 10.1016/j.cbi.2021.109652. Epub 2021 Sep 11.
339 RhoA/MLC signaling pathway is involved in ?-tetrahydrocannabinol-impaired placental angiogenesis. Toxicol Lett. 2018 Mar 15;285:148-155. doi: 10.1016/j.toxlet.2017.12.031. Epub 2018 Jan 4.
340 Possible roles for folic acid in the regulation of trophoblast invasion and placental development in normal early human pregnancy. Biol Reprod. 2011 Jun;84(6):1148-53. doi: 10.1095/biolreprod.110.088351. Epub 2011 Feb 23.
341 Rosiglitazone impairs proliferation of human adrenocortical cancer: preclinical study in a xenograft mouse model. Endocr Relat Cancer. 2010 Feb 18;17(1):169-77. doi: 10.1677/ERC-09-0170. Print 2010 Mar.
342 Effects of niacin on cell adhesion and early atherogenesis: biochemical and functional findings in endothelial cells. Basic Clin Pharmacol Toxicol. 2009 Mar;104(3):206-10. doi: 10.1111/j.1742-7843.2008.00364.x. Epub 2009 Jan 21.
343 Vitamin E inhibits lipid peroxidation-induced adhesion molecule expression in endothelial cells and decreases soluble cell adhesion molecules in healthy subjects. Cardiovasc Res. 2003 Feb;57(2):563-71. doi: 10.1016/s0008-6363(02)00699-5.
344 Reduction of synovial sublining layer inflammation and proinflammatory cytokine expression in psoriatic arthritis treated with methotrexate. Arthritis Rheum. 2004 Oct;50(10):3286-95. doi: 10.1002/art.20518.
345 Effects of bezafibrate and simvastatin on endothelial activation and lipid peroxidation in hypercholesterolemia: evidence of different vascular protection by different lipid-lowering treatments. J Clin Endocrinol Metab. 2003 Nov;88(11):5341-7. doi: 10.1210/jc.2003-030724.
346 Bile acids induce adhesion molecule expression in endothelial cells through activation of reactive oxygen species, NF-kappaB, and p38. Am J Physiol Heart Circ Physiol. 2006 Aug;291(2):H741-7. doi: 10.1152/ajpheart.01182.2005. Epub 2006 Mar 31.
347 Retinoic acid receptor alpha amplifications and retinoic acid sensitivity in breast cancers. Clin Breast Cancer. 2013 Oct;13(5):401-8.
348 The in vitro effects of quinupristin/dalfopristin, erythromycin and levofloxacin at low concentrations on the expression of different cell adhesion molecules on the surface of endothelial cells (Eahy926). Toxicology. 2006 Jan 20;218(1):30-8. doi: 10.1016/j.tox.2005.09.014. Epub 2005 Nov 16.
349 Effects of hormone treatment on hemostasis variables. Climacteric. 2007 Oct;10 Suppl 2:32-7. doi: 10.1080/13697130701598548.
350 Markers of inflammation, thrombosis and endothelial activation correlate with carotid IMT regression in stable coronary disease after atorvastatin treatment. Nutr Metab Cardiovasc Dis. 2009 Sep;19(7):481-90. doi: 10.1016/j.numecd.2008.10.003. Epub 2009 Jan 26.
351 Modulation of endothelial cell activation in sickle cell disease: a pilot study. Blood. 2001 Apr 1;97(7):1937-41. doi: 10.1182/blood.v97.7.1937.
352 Rapid effects of rosiglitazone treatment on endothelial function and inflammatory biomarkers. Arterioscler Thromb Vasc Biol. 2005 Sep;25(9):1804-9. doi: 10.1161/01.ATV.0000176192.16951.9a. Epub 2005 Jul 7.
353 Protein expression profiling identifies molecular targets of quercetin as a major dietary flavonoid in human colon cancer cells. Proteomics. 2004 Jul;4(7):2160-74.
354 Stathmin is involved in arsenic trioxide-induced apoptosis in human cervical cancer cell lines via PI3K linked signal pathway. Cancer Biol Ther. 2010 Sep 15;10(6):632-43. doi: 10.4161/cbt.10.6.12654. Epub 2010 Sep 13.
355 Quantitative proteomic analysis of HepG2 cells treated with quercetin suggests IQGAP1 involved in quercetin-induced regulation of cell proliferation and migration. OMICS. 2009 Apr;13(2):93-103. doi: 10.1089/omi.2008.0075.
356 Arsenic trioxide induces Hsp70 expression via reactive oxygen species and JNK pathway in MDA231 cells. Life Sci. 2005 Oct 14;77(22):2783-93. doi: 10.1016/j.lfs.2005.04.024.
357 Effect of all-trans retinoic acid on sodium/iodide symporter expression, radioiodine uptake and gene expression profiles in a human anaplastic thyroid carcinoma cell line. Nucl Med Biol. 2006 Oct;33(7):875-82. doi: 10.1016/j.nucmedbio.2006.07.004.
358 Motexafin gadolinium and zinc induce oxidative stress responses and apoptosis in B-cell lymphoma lines. Cancer Res. 2005 Dec 15;65(24):11676-88.
359 Robustness testing and optimization of an adverse outcome pathway on cholestatic liver injury. Arch Toxicol. 2020 Apr;94(4):1151-1172. doi: 10.1007/s00204-020-02691-9. Epub 2020 Mar 10.
360 DNA array analysis of the effects of aspirin on colon cancer cells: involvement of Rac1. Carcinogenesis. 2004 Jul;25(7):1293-8.
361 JunD is involved in the antiproliferative effect of Delta9-tetrahydrocannabinol on human breast cancer cells. Oncogene. 2008 Aug 28;27(37):5033-44.
362 Amiodarone sensitizes human glioma cells but not astrocytes to TRAIL-induced apoptosis via CHOP-mediated DR5 upregulation. Neuro Oncol. 2011 Mar;13(3):267-79. doi: 10.1093/neuonc/noq195. Epub 2011 Feb 3.
363 Rifampicin-induced injury in L02 cells is alleviated by 4-PBA via inhibition of the PERK-ATF4-CHOP pathway. Toxicol In Vitro. 2016 Oct;36:186-196. doi: 10.1016/j.tiv.2016.07.017. Epub 2016 Jul 26.
364 Dexamethasone and the inflammatory response in explants of human omental adipose tissue. Mol Cell Endocrinol. 2010 Feb 5;315(1-2):292-8.
365 Identification of genes linked to gefitinib treatment in prostate cancer cell lines with or without resistance to androgen: a clue to application of gefitinib to hormone-resistant prostate cancer. Oncol Rep. 2006 Jun;15(6):1453-60.
366 The thioredoxin system mediates redox-induced cell death in human colon cancer cells: implications for the mechanism of action of anticancer agents. Cancer Res. 2008 Oct 15;68(20):8269-77. doi: 10.1158/0008-5472.CAN-08-2010.
367 Development of an alternative zebrafish model for drug-induced intestinal toxicity. J Appl Toxicol. 2018 Feb;38(2):259-273. doi: 10.1002/jat.3520. Epub 2017 Oct 13.
368 Suppression of RAGE as a basis of simvastatin-dependent plaque stabilization in type 2 diabetes. Arterioscler Thromb Vasc Biol. 2006 Dec;26(12):2716-23.
369 Quercetin potentiates apoptosis by inhibiting nuclear factor-kappaB signaling in H460 lung cancer cells. Biol Pharm Bull. 2013;36(6):944-51. doi: 10.1248/bpb.b12-01004.
370 Rapamycin sensitizes multiple myeloma cells to apoptosis induced by dexamethasone. Blood. 2004 Apr 15;103(8):3138-47. doi: 10.1182/blood-2003-05-1543. Epub 2003 Dec 24.
371 EGFR tyrosine kinase inhibitors activate autophagy as a cytoprotective response in human lung cancer cells. PLoS One. 2011;6(6):e18691. doi: 10.1371/journal.pone.0018691. Epub 2011 Jun 2.
372 Oxidative stress induces parallel autophagy and mitochondria dysfunction in human glioma U251 cells. Toxicol Sci. 2009 Aug;110(2):376-88. doi: 10.1093/toxsci/kfp101. Epub 2009 May 18.
373 Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem J. 2000 Oct 1;351(Pt 1):95-105.
374 SU5416 inhibited VEGF and HIF-1alpha expression through the PI3K/AKT/p70S6K1 signaling pathway. Biochem Biophys Res Commun. 2004 Nov 12;324(2):471-80. doi: 10.1016/j.bbrc.2004.09.082.
375 Differential modulation of PI3-kinase/Akt pathway during all-trans retinoic acid- and Am80-induced HL-60 cell differentiation revealed by DNA microarray analysis. Biochem Pharmacol. 2004 Dec 1;68(11):2177-86.
376 D-glucosamine down-regulates HIF-1alpha through inhibition of protein translation in DU145 prostate cancer cells. Biochem Biophys Res Commun. 2009 Apr 24;382(1):96-101. doi: 10.1016/j.bbrc.2009.02.129. Epub 2009 Feb 28.
377 Arsenic trioxide inhibits translation of mRNA of bcr-abl, resulting in attenuation of Bcr-Abl levels and apoptosis of human leukemia cells. Cancer Res. 2003 Nov 15;63(22):7950-8.
378 Dominant roles of the Raf/MEK/ERK pathway in cell cycle progression, prevention of apoptosis and sensitivity to chemotherapeutic drugs. Cell Cycle. 2010 Apr 15;9(8):1629-38. doi: 10.4161/cc.9.8.11487. Epub 2010 Apr 15.
379 Chromium III histidinate exposure modulates gene expression in HaCaT human keratinocytes exposed to oxidative stress. Biol Trace Elem Res. 2010 Oct;137(1):23-39.
380 A dual role of p21waf1/cip1 gene in apoptosis of HEp-2 treated with cisplatin or methotrexate. Cancer Gene Ther. 2008 Sep;15(9):576-90. doi: 10.1038/cgt.2008.28. Epub 2008 May 16.
381 Genomic profiling uncovers a molecular pattern for toxicological characterization of mutagens and promutagens in vitro. Toxicol Sci. 2011 Jul;122(1):185-97.
382 Quercetin and Its Fermented Extract as a Potential Inhibitor of Bisphenol A-Exposed HT-29 Colon Cancer Cells' Viability. Int J Mol Sci. 2023 Mar 15;24(6):5604. doi: 10.3390/ijms24065604.
383 The Effect of GADD45a on Furazolidone-Induced S-Phase Cell-Cycle Arrest in Human Hepatoma G2 Cells. J Biochem Mol Toxicol. 2015 Oct;29(10):489-495. doi: 10.1002/jbt.21719. Epub 2015 Jun 11.
384 Signaling pathways involved in induction of GADD45 gene expression and apoptosis by troglitazone in human MCF-7 breast carcinoma cells. Oncogene. 2004 Jun 3;23(26):4614-23. doi: 10.1038/sj.onc.1207598.
385 Treatment with anticancer agents induces dysregulation of specific Wnt signaling pathways in human ovarian luteinized granulosa cells in vitro. Toxicol Sci. 2013 Nov;136(1):183-92. doi: 10.1093/toxsci/kft175. Epub 2013 Aug 16.
386 Progesterone increases csk homologous kinase in HMC-1560 human mast cells and reduces cell proliferation. J Cell Biochem. 2007 Dec 1;102(5):1271-80. doi: 10.1002/jcb.21357.
387 Cannabidiol upregulates melanogenesis through CB1 dependent pathway by activating p38 MAPK and p42/44 MAPK. Chem Biol Interact. 2017 Aug 1;273:107-114. doi: 10.1016/j.cbi.2017.06.005. Epub 2017 Jun 7.
388 Growth stimulation of human pulmonary adenocarcinoma cells and small airway epithelial cells by beta-carotene via activation of cAMP, PKA, CREB and ERK1/2. Int J Cancer. 2006 Mar 15;118(6):1370-80. doi: 10.1002/ijc.21537.
389 Estrogen and pure antiestrogen fulvestrant (ICI 182 780) augment cell-matrigel adhesion of MCF-7 breast cancer cells through a novel G protein coupled estrogen receptor (GPR30)-to-calpain signaling axis. Toxicol Appl Pharmacol. 2014 Mar 1;275(2):176-81. doi: 10.1016/j.taap.2014.01.005. Epub 2014 Jan 17.
390 Inhibition of activator protein 1 by barbiturates is mediated by differential effects on mitogen-activated protein kinases and the small G proteins ras and rac-1. J Pharmacol Exp Ther. 2004 Dec;311(3):1232-40. doi: 10.1124/jpet.104.071332. Epub 2004 Jul 19.
391 Growth of hormone-dependent MCF-7 breast cancer cells is promoted by constitutive caveolin-1 whose expression is lost in an EGF-R-mediated manner during development of tamoxifen resistance. Breast Cancer Res Treat. 2010 Feb;119(3):575-91. doi: 10.1007/s10549-009-0355-8. Epub 2009 Mar 15.
392 Effect of histamine H1 receptor antagonists on TARC/CCL17 and MDC/CCL22 production from CD14+ cells induced by antigenic stimulation in vitro. Int Arch Allergy Immunol. 2011;155(1):38-51. doi: 10.1159/000318720. Epub 2010 Nov 25.
393 SIRT3 Mediates the Antioxidant Effect of Hydrogen Sulfide in Endothelial Cells. Antioxid Redox Signal. 2016 Feb 20;24(6):329-43. doi: 10.1089/ars.2015.6331. Epub 2015 Nov 10.
394 Imiquimod induces apoptosis of human melanocytes. Arch Dermatol Res. 2010 May;302(4):301-6. doi: 10.1007/s00403-009-1012-0. Epub 2009 Dec 23.
395 Downregulation of mitogen-activated protein kinases (MAPKs) in chronic ethanol-induced fatty liver. Toxicol Mech Methods. 2020 Jul;30(6):407-416. doi: 10.1080/15376516.2020.1747126. Epub 2020 Apr 1.
396 A unique mechanism of beta-blocker action: carvedilol stimulates beta-arrestin signaling. Proc Natl Acad Sci U S A. 2007 Oct 16;104(42):16657-62. doi: 10.1073/pnas.0707936104. Epub 2007 Oct 9.
397 The stent-eluting drugs sirolimus and paclitaxel suppress healing of the endothelium by induction of autophagy. Am J Pathol. 2009 Nov;175(5):2226-34.
398 Modulation of apoptosis in HaCaT keratinocytes via differential regulation of ERK signaling pathway by flavonoids. J Biol Chem. 2005 Sep 9;280(36):31498-507. doi: 10.1074/jbc.M505537200. Epub 2005 Jul 13.
399 Neuroprotective effects of glucomoringin-isothiocyanate against H(2)O(2)-Induced cytotoxicity in neuroblastoma (SH-SY5Y) cells. Neurotoxicology. 2019 Dec;75:89-104. doi: 10.1016/j.neuro.2019.09.008. Epub 2019 Sep 12.
400 Complex genetic response of human cells to sublethal levels of pure nitric oxide. Cancer Res. 1998 Aug 1;58(15):3435-40.
401 Effects of chlorpromazine with and without UV irradiation on gene expression of HepG2 cells. Mutat Res. 2005 Aug 4;575(1-2):47-60. doi: 10.1016/j.mrfmmm.2005.03.002. Epub 2005 Apr 26.
402 Induction of CCAAT/enhancer-binding protein-homologous protein by cigarette smoke through the superoxide anion-triggered PERK-eIF2 pathway. Toxicology. 2011 Sep 5;287(1-3):105-12. doi: 10.1016/j.tox.2011.06.005. Epub 2011 Jun 15.
403 High-content imaging-based BAC-GFP toxicity pathway reporters to assess chemical adversity liabilities. Arch Toxicol. 2017 Mar;91(3):1367-1383. doi: 10.1007/s00204-016-1781-0. Epub 2016 Jun 29.
404 Utilization of causal reasoning of hepatic gene expression in rats to identify molecular pathways of idiosyncratic drug-induced liver injury. Toxicol Sci. 2014 Jan;137(1):234-48. doi: 10.1093/toxsci/kft232. Epub 2013 Oct 17.
405 Involvement of the activation of Nrf2/HO-1, p38 MAPK signaling pathways and endoplasmic reticulum stress in furazolidone induced cytotoxicity and S phase arrest in human hepatocyte L02 cells: modulation of curcumin. Toxicol Mech Methods. 2017 Mar;27(3):165-172. doi: 10.1080/15376516.2016.1273424. Epub 2017 Jan 8.
406 Large-scale in silico and microarray-based identification of direct 1,25-dihydroxyvitamin D3 target genes. Mol Endocrinol. 2005 Nov;19(11):2685-95.
407 eIF4E is a critical regulator of human papillomavirus (HPV)-immortalized cervical epithelial (H8) cell growth induced by nicotine. Toxicology. 2019 May 1;419:1-10. doi: 10.1016/j.tox.2019.02.017. Epub 2019 Mar 2.
408 Transcriptomic Analysis of Stem Cells Treated with Moringin or Cannabidiol: Analogies and Differences in Inflammation Pathways. Int J Mol Sci. 2019 Nov 30;20(23):6039. doi: 10.3390/ijms20236039.
409 Repression of Kisspeptin1 weakens hydrogen peroxide-caused injury in HTR8 cells via adjusting PI3K/AKT/mTOR pathway. J Biochem Mol Toxicol. 2020 May;34(5):e22461. doi: 10.1002/jbt.22461. Epub 2020 Feb 11.
410 Establishment of a 13 genes-based molecular prediction score model to discriminate the neurotoxic potential of food relevant-chemicals. Toxicol Lett. 2022 Feb 1;355:1-18. doi: 10.1016/j.toxlet.2021.10.013. Epub 2021 Nov 5.
411 Quercetin inhibits angiogenesis mediated human prostate tumor growth by targeting VEGFR- 2 regulated AKT/mTOR/P70S6K signaling pathways. PLoS One. 2012;7(10):e47516. doi: 10.1371/journal.pone.0047516. Epub 2012 Oct 18.
412 A comprehensive analysis of Wnt/beta-catenin signaling pathway-related genes and crosstalk pathways in the treatment of As2O3 in renal cancer. Ren Fail. 2018 Nov;40(1):331-339.
413 Hydroquinone-induced endoplasmic reticulum stress affects TK6 cell autophagy and apoptosis via ATF6-mTOR. Environ Toxicol. 2023 Aug;38(8):1874-1890. doi: 10.1002/tox.23814. Epub 2023 May 6.
414 Different apoptosis ratios and gene expressions in two human cell lines after sevoflurane anaesthesia. Acta Anaesthesiol Scand. 2009 Oct;53(9):1192-9. doi: 10.1111/j.1399-6576.2009.02036.x. Epub 2009 Jun 30.
415 [Mechanisms underlying the effect of arsenic trioxide on proliferation inhibition and apoptosis induction in myeloma cell line u266]. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2007 Oct;15(5):982-5.
416 Lovastatin lactone elicits human lung cancer cell apoptosis via a COX-2/PPAR-dependent pathway. Oncotarget. 2016 Mar 1;7(9):10345-62. doi: 10.18632/oncotarget.7213.
417 Induction of apoptosis by cidofovir in human papillomavirus (HPV)-positive cells. Oncol Res. 2000;12(9-10):397-408. doi: 10.3727/096504001108747855.
418 Comparison of burst of reactive oxygen species and activation of caspase-3 in apoptosis of K562 and HL-60 cells induced by docetaxel. Cancer Lett. 2004 Oct 8;214(1):103-13. doi: 10.1016/j.canlet.2004.03.047.
419 Induction of mitochondrial manganese superoxide dismutase confers resistance to apoptosis in acute myeloblastic leukaemia cells exposed to etoposide. Br J Haematol. 2000 Mar;108(3):574-81. doi: 10.1046/j.1365-2141.2000.01852.x.
420 Cisplatin-enhanced sensitivity of glioblastoma multiforme U251 cells to adenovirus-delivered TRAIL in vitro. Tumour Biol. 2010 Dec;31(6):613-22. doi: 10.1007/s13277-010-0077-x. Epub 2010 Jul 11.
421 Insulin-like growth factor I is the key growth factor in serum that protects neuroblastoma cells from hyperosmotic-induced apoptosis. J Cell Physiol. 2000 Jan;182(1):24-32. doi: 10.1002/(SICI)1097-4652(200001)182:1<24::AID-JCP3>3.0.CO;2-6.
422 mRNA expression analysis of a variety of apoptosis-related genes, including the novel gene of the BCL2-family, BCL2L12, in HL-60 leukemia cells after treatment with carboplatin and doxorubicin. Biol Chem. 2004 Nov;385(11):1099-103. doi: 10.1515/BC.2004.143.
423 Neurokinin-1 receptor (NK1R) inhibition sensitizes APL cells to anti-tumor effect of arsenic trioxide via restriction of NF-B axis: Shedding new light on resistance to Aprepitant. Int J Biochem Cell Biol. 2018 Oct;103:105-114. doi: 10.1016/j.biocel.2018.08.010. Epub 2018 Aug 23.
424 LSD1 activates a lethal prostate cancer gene network independently of its demethylase function. Proc Natl Acad Sci U S A. 2018 May 1;115(18):E4179-E4188.
425 Expression and DNA methylation changes in human breast epithelial cells after bisphenol A exposure. Int J Oncol. 2012 Jul;41(1):369-77.
426 ST1926, a novel and orally active retinoid-related molecule inducing apoptosis in myeloid leukemia cells: modulation of intracellular calcium homeostasis. Blood. 2004 Jan 1;103(1):194-207.
427 Quercetin induced cell apoptosis and altered gene expression in AGS human gastric cancer cells. Environ Toxicol. 2018 Nov;33(11):1168-1181. doi: 10.1002/tox.22623. Epub 2018 Aug 27.
428 Arsenic trioxide (As(2)O(3)) induced apoptosis and its mechanisms in a human esophageal squamous carcinoma cell line. Chin Med J (Engl). 2002 Feb;115(2):280-5.
429 Role of unfolded protein response dysregulation in oxidative injury of retinal pigment epithelial cells. Antioxid Redox Signal. 2014 May 10;20(14):2091-106. doi: 10.1089/ars.2013.5240. Epub 2013 Dec 17.
430 Ouabain induces apoptotic cell death in human prostate DU 145 cancer cells through DNA damage and TRAIL pathways. Environ Toxicol. 2019 Dec;34(12):1329-1339. doi: 10.1002/tox.22834. Epub 2019 Aug 21.
431 A comparative proteomic analysis for capsaicin-induced apoptosis between human hepatocarcinoma (HepG2) and human neuroblastoma (SK-N-SH) cells. Proteomics. 2008 Nov;8(22):4748-67. doi: 10.1002/pmic.200800094.
432 Extremely low copper concentrations affect gene expression profiles of human prostate epithelial cell lines. Chem Biol Interact. 2010 Oct 6;188(1):214-9.
433 Activation of AIFM2 enhances apoptosis of human lung cancer cells undergoing toxicological stress. Toxicol Lett. 2016 Sep 6;258:227-236.
434 Cannabidiol Effectively Promoted Cell Death in Bladder Cancer and the Improved Intravesical Adhesion Drugs Delivery Strategy Could Be Better Used for Treatment. Pharmaceutics. 2021 Sep 7;13(9):1415. doi: 10.3390/pharmaceutics13091415.
435 A model to identify novel targets involved in oxidative stress-induced apoptosis in human lung epithelial cells by RNA interference. Toxicol In Vitro. 2010 Feb;24(1):310-8. doi: 10.1016/j.tiv.2009.08.008. Epub 2009 Aug 23.
436 Nitric oxide inhibits execution of apoptosis at two distinct ATP-dependent steps upstream and downstream of mitochondrial cytochrome c release. Biochem Biophys Res Commun. 1999 Apr 29;258(1):215-21. doi: 10.1006/bbrc.1999.0491.
437 Palmitate increases the susceptibility of cells to drug-induced toxicity: an in vitro method to identify drugs with potential contraindications in patients with metabolic disease. Toxicol Sci. 2012 Oct;129(2):346-62. doi: 10.1093/toxsci/kfs208. Epub 2012 Jun 14.
438 Simvastatin induces apoptosis and alters cytoskeleton in endometrial stromal cells. J Clin Endocrinol Metab. 2010 Jul;95(7):3453-9. doi: 10.1210/jc.2010-0072. Epub 2010 Apr 28.
439 The involvement of hepatic cytochrome P450s in the cytotoxicity of lapatinib. Toxicol Sci. 2023 Dec 21;197(1):69-78. doi: 10.1093/toxsci/kfad099.
440 Synergistic effects of chemotherapeutic drugs in lymphoma cells are associated with down-regulation of inhibitor of apoptosis proteins (IAPs), prostate-apoptosis-response-gene 4 (Par-4), death-associated protein (Daxx) and with enforced caspase activation. Biochem Pharmacol. 2003 Sep 1;66(5):711-24. doi: 10.1016/s0006-2952(03)00410-6.
441 Genistein and bisphenol A exposure cause estrogen receptor 1 to bind thousands of sites in a cell type-specific manner. Genome Res. 2012 Nov;22(11):2153-62.
442 Nicotinic modulation of gene expression in SH-SY5Y neuroblastoma cells. Brain Res. 2006 Oct 20;1116(1):39-49.
443 Reproducible chemical-induced changes in gene expression profiles in human hepatoma HepaRG cells under various experimental conditions. Toxicol In Vitro. 2009 Apr;23(3):466-75. doi: 10.1016/j.tiv.2008.12.018. Epub 2008 Dec 30.
444 Bisphenol A induces DSB-ATM-p53 signaling leading to cell cycle arrest, senescence, autophagy, stress response, and estrogen release in human fetal lung fibroblasts. Arch Toxicol. 2018 Apr;92(4):1453-1469.
445 Transcriptional profiling of lactic acid treated reconstructed human epidermis reveals pathways underlying stinging and itch. Toxicol In Vitro. 2019 Jun;57:164-173.
446 Zoledronate dysregulates fatty acid metabolism in renal tubular epithelial cells to induce nephrotoxicity. Arch Toxicol. 2018 Jan;92(1):469-485.
447 Cannabidiol Displays Proteomic Similarities to Antipsychotics in Cuprizone-Exposed Human Oligodendrocytic Cell Line MO3.13. Front Mol Neurosci. 2021 May 28;14:673144. doi: 10.3389/fnmol.2021.673144. eCollection 2021.
448 Apoptosis induced by piroxicam plus cisplatin combined treatment is triggered by p21 in mesothelioma. PLoS One. 2011;6(8):e23569.
449 Genome-wide analysis of BEAS-2B cells exposed to trivalent arsenicals and dimethylthioarsinic acid. Toxicology. 2010 Jan 31;268(1-2):31-9.
450 Gene Expression Regulation and Pathway Analysis After Valproic Acid and Carbamazepine Exposure in a Human Embryonic Stem Cell-Based Neurodevelopmental Toxicity Assay. Toxicol Sci. 2015 Aug;146(2):311-20. doi: 10.1093/toxsci/kfv094. Epub 2015 May 15.
451 MiR-146a affects the alteration in myeloid differentiation induced by hydroquinone in human CD34(+) hematopoietic progenitor cells and HL-60 cells. Toxicol Res (Camb). 2016 Feb 16;5(3):848-858. doi: 10.1039/c5tx00419e. eCollection 2016 May 1.
452 Cannabidiol and Oxygen-Ozone Combination Induce Cytotoxicity in Human Pancreatic Ductal Adenocarcinoma Cell Lines. Cancers (Basel). 2020 Sep 27;12(10):2774. doi: 10.3390/cancers12102774.
453 Integrated assessment by multiple gene expression analysis of quercetin bioactivity on anticancer-related mechanisms in colon cancer cells in vitro. Eur J Nutr. 2005 Mar;44(3):143-56. doi: 10.1007/s00394-004-0503-1. Epub 2004 Apr 30.
454 The role of MITF and Mcl-1 proteins in the antiproliferative and proapoptotic effect of ciprofloxacin in amelanotic melanoma cells: In silico and in vitro study. Toxicol In Vitro. 2020 Aug;66:104884. doi: 10.1016/j.tiv.2020.104884. Epub 2020 May 8.
455 Peripheral blood expression of nuclear factor-kappab-regulated genes is associated with rheumatoid arthritis disease activity and responds differentially to anti-tumor necrosis factor-alpha versus methotrexate. J Rheumatol. 2007 Sep;34(9):1817-22. Epub 2007 Aug 1.
456 Quercetin downregulates Mcl-1 by acting on mRNA stability and protein degradation. Br J Cancer. 2011 Jul 12;105(2):221-30. doi: 10.1038/bjc.2011.229.
457 Multifaceted preventive effects of single agent quercetin on a human prostate adenocarcinoma cell line (PC-3): implications for nutritional transcriptomics and multi-target therapy. Med Oncol. 2011 Dec;28(4):1395-404. doi: 10.1007/s12032-010-9603-3. Epub 2010 Jul 2.
458 Anti-cancer properties of glucosamine-hydrochloride in YD-8 human oral cancer cells: Induction of the caspase-dependent apoptosis and down-regulation of HIF-1. Toxicol In Vitro. 2012 Feb;26(1):42-50. doi: 10.1016/j.tiv.2011.10.005. Epub 2011 Oct 13.
459 Ethacrynic acid and a derivative enhance apoptosis in arsenic trioxide-treated myeloid leukemia and lymphoma cells: the role of glutathione S-transferase p1-1. Clin Cancer Res. 2012 Dec 15;18(24):6690-701. doi: 10.1158/1078-0432.CCR-12-0770. Epub 2012 Oct 18.
460 [Effect of arsenic trioxide on apoptosis in lymphoblastoid Raji cell line with relation to expression of mcl-1 gene]. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2009 Jun;17(3):597-601.
461 Comparison of the effects of metoclopramide and domperidone on HERG channels. Pharmacology. 2005 Apr;74(1):31-6. doi: 10.1159/000083234. Epub 2005 Jan 7.
462 Further insights into the effect of quinidine in short QT syndrome caused by a mutation in HERG. J Cardiovasc Electrophysiol. 2005 Jan;16(1):54-8. doi: 10.1046/j.1540-8167.2005.04470.x.
463 Automated tight seal electrophysiology for assessing the potential hERG liability of pharmaceutical compounds. Assay Drug Dev Technol. 2004 Oct;2(5):497-506. doi: 10.1089/adt.2004.2.497.
464 Refining the human iPSC-cardiomyocyte arrhythmic risk assessment model. Toxicol Sci. 2013 Dec;136(2):581-94. doi: 10.1093/toxsci/kft205. Epub 2013 Sep 19.
465 Pharmacology of the short QT syndrome N588K-hERG K+ channel mutation: differential impact on selected class I and class III antiarrhythmic drugs. Br J Pharmacol. 2008 Nov;155(6):957-66. doi: 10.1038/bjp.2008.325. Epub 2008 Aug 25.
466 Comparison of HERG channel blocking effects of various beta-blockers-- implication for clinical strategy. Br J Pharmacol. 2006 Mar;147(6):642-52. doi: 10.1038/sj.bjp.0706508.
467 Inhibitory effects of the class III antiarrhythmic drug amiodarone on cloned HERG potassium channels. Naunyn Schmiedebergs Arch Pharmacol. 1999 Mar;359(3):212-9. doi: 10.1007/pl00005344.
468 Redox state dependency of HERGS631C channel pharmacology: relation to C-type inactivation. FEBS Lett. 2000 May 26;474(1):111-5. doi: 10.1016/s0014-5793(00)01586-6.
469 Multi-parameter in vitro toxicity testing of crizotinib, sunitinib, erlotinib, and nilotinib in human cardiomyocytes. Toxicol Appl Pharmacol. 2013 Oct 1;272(1):245-55.
470 Adipocyte differentiation, mitochondrial gene expression and fat distribution: differences between zidovudine and tenofovir after 6 months. Antivir Ther. 2009;14(8):1089-100. doi: 10.3851/IMP1457.
471 Temporal changes in gene expression in the skin of patients treated with isotretinoin provide insight into its mechanism of action. Dermatoendocrinol. 2009 May;1(3):177-87.
472 Comparative effects of fructose and glucose on lipogenic gene expression and intermediary metabolism in HepG2 liver cells. PLoS One. 2011;6(11):e26583. doi: 10.1371/journal.pone.0026583. Epub 2011 Nov 11.
473 Aspirin regulates hepatocellular lipid metabolism by activating AMPK signaling pathway. J Toxicol Sci. 2015 Feb;40(1):127-36. doi: 10.2131/jts.40.127.
474 Febuxostat Increases Ventricular Arrhythmogenesis Through Calcium Handling Dysregulation in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes. Toxicol Sci. 2022 Sep 24;189(2):216-224. doi: 10.1093/toxsci/kfac073.
475 Mitochondrial Uncoupling Induces Epigenome Remodeling and Promotes Differentiation in Neuroblastoma. Cancer Res. 2023 Jan 18;83(2):181-194. doi: 10.1158/0008-5472.CAN-22-1029.
476 Transcriptomics and methylomics of CD4-positive T cells in arsenic-exposed women. Arch Toxicol. 2017 May;91(5):2067-2078. doi: 10.1007/s00204-016-1879-4. Epub 2016 Nov 12.
477 Autophagy Inhibition Overcomes the Antagonistic Effect Between Gefitinib and Cisplatin in Epidermal Growth Factor Receptor Mutant Non--Small-Cell Lung Cancer Cells. Clin Lung Cancer. 2015 Sep;16(5):e55-66. doi: 10.1016/j.cllc.2015.03.006. Epub 2015 Apr 2.
478 Harnessing autophagy to overcome mitogen-activated protein kinase kinase inhibitor-induced resistance in metastatic melanoma. Br J Dermatol. 2019 Feb;180(2):346-356. doi: 10.1111/bjd.17333. Epub 2018 Nov 25.
479 Systems analysis of transcriptome and proteome in retinoic acid/arsenic trioxide-induced cell differentiation/apoptosis of promyelocytic leukemia. Proc Natl Acad Sci U S A. 2005 May 24;102(21):7653-8.
480 Induction of heme oxygenase-1 by cobalt protoporphyrin enhances the antitumour effect of bortezomib in adult T-cell leukaemia cells. Br J Cancer. 2007 Oct 22;97(8):1099-105. doi: 10.1038/sj.bjc.6604003. Epub 2007 Sep 25.
481 Proteomic analysis of the cellular response to a potent sensitiser unveils the dynamics of haptenation in living cells. Toxicology. 2020 Dec 1;445:152603. doi: 10.1016/j.tox.2020.152603. Epub 2020 Sep 28.
482 Growth-suppressive effect of non-steroidal anti-inflammatory drugs on 11 colon-cancer cell lines and fluorescence differential display of genes whose expression is influenced by sulindac. Int J Cancer. 2000 Dec 15;88(6):873-80. doi: 10.1002/1097-0215(20001215)88:6<873::aid-ijc6>3.0.co;2-b.
483 Inter-laboratory comparison of human renal proximal tubule (HK-2) transcriptome alterations due to Cyclosporine A exposure and medium exhaustion. Toxicol In Vitro. 2009 Apr;23(3):486-99.
484 Successful validation of genomic biomarkers for human immunotoxicity in Jurkat T cells in vitro. J Appl Toxicol. 2015 Jul;35(7):831-41.
485 Identification by automated screening of a small molecule that selectively eliminates neural stem cells derived from hESCs but not dopamine neurons. PLoS One. 2009 Sep 23;4(9):e7155.
486 eNOS activation mediated by AMPK after stimulation of endothelial cells with histamine or thrombin is dependent on LKB1. Biochim Biophys Acta. 2011 Feb;1813(2):322-31. doi: 10.1016/j.bbamcr.2010.12.001. Epub 2010 Dec 9.
487 2-Deoxy-D-glucose cooperates with arsenic trioxide to induce apoptosis in leukemia cells: involvement of IGF-1R-regulated Akt/mTOR, MEK/ERK and LKB-1/AMPK signaling pathways. Biochem Pharmacol. 2012 Dec 15;84(12):1604-16. doi: 10.1016/j.bcp.2012.09.022. Epub 2012 Oct 5.
488 Effects of metformin and pioglitazone combination on apoptosis and AMPK/mTOR signaling pathway in human anaplastic thyroid cancer cells. J Biochem Mol Toxicol. 2020 Oct;34(10):e22547. doi: 10.1002/jbt.22547. Epub 2020 Jun 26.
489 Resveratrol activates duodenal Sirt1 to reverse insulin resistance in rats through a neuronal network. Nat Med. 2015 May;21(5):498-505. doi: 10.1038/nm.3821. Epub 2015 Apr 6.
490 Mutant p53 reactivation by PRIMA-1MET induces multiple signaling pathways converging on apoptosis. Oncogene. 2010 Mar 4;29(9):1329-38. doi: 10.1038/onc.2009.425. Epub 2009 Nov 30.
491 Phosphoinositide 3-kinase (PI3K) pathway alterations are associated with histologic subtypes and are predictive of sensitivity to PI3K inhibitors in lung cancer preclinical models. Clin Cancer Res. 2012 Dec 15;18(24):6771-83. doi: 10.1158/1078-0432.CCR-12-2347. Epub 2012 Nov 7.
492 Effect of aflatoxin B(1), benzo[a]pyrene, and methapyrilene on transcriptomic and epigenetic alterations in human liver HepaRG cells. Food Chem Toxicol. 2018 Nov;121:214-223. doi: 10.1016/j.fct.2018.08.034. Epub 2018 Aug 26.
493 Gingival Stromal Cells as an In Vitro Model: Cannabidiol Modulates Genes Linked With Amyotrophic Lateral Sclerosis. J Cell Biochem. 2017 Apr;118(4):819-828. doi: 10.1002/jcb.25757. Epub 2016 Nov 28.
494 Protective role of HO-1 for alcohol-dependent liver damage. Dig Dis. 2010;28(6):792-8. doi: 10.1159/000324287. Epub 2011 Apr 27.
495 Gypenosides protect retinal pigment epithelium cells from oxidative stress. Food Chem Toxicol. 2018 Feb;112:76-85.
496 Distinct Nrf2 Signaling Mechanisms of Fumaric Acid Esters and Their Role in Neuroprotection against 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Induced Experimental Parkinson's-Like Disease. J Neurosci. 2016 Jun 8;36(23):6332-51. doi: 10.1523/JNEUROSCI.0426-16.2016.
497 Simvastatin protects dopaminergic neurons against MPP+-induced oxidative stress and regulates the endogenous anti-oxidant system through ERK. Cell Physiol Biochem. 2018;51(4):1957-1968.
498 P450 3A-catalyzed O-dealkylation of lapatinib induces mitochondrial stress and activates Nrf2. Chem Res Toxicol. 2016 May 16;29(5):784-96.
499 P21(Waf1/Cip1) plays a critical role in furazolidone-induced apoptosis in HepG2 cells through influencing the caspase-3 activation and ROS generation. Food Chem Toxicol. 2016 Feb;88:1-12. doi: 10.1016/j.fct.2015.12.004. Epub 2015 Dec 11.
500 Gene expression in endometrial cancer cells (Ishikawa) after short time high dose exposure to progesterone. Steroids. 2008 Jan;73(1):116-28.
501 Gene expression profile analysis of 4-phenylbutyrate treatment of IB3-1 bronchial epithelial cell line demonstrates a major influence on heat-shock proteins. Physiol Genomics. 2004 Jan 15;16(2):204-11.
502 Lipid Rafts Disruption Increases Ochratoxin A Cytotoxicity to Hepatocytes. J Biochem Mol Toxicol. 2016 Feb;30(2):71-9. doi: 10.1002/jbt.21738. Epub 2015 Aug 25.
503 DNA methylome-wide alterations associated with estrogen receptor-dependent effects of bisphenols in breast cancer. Clin Epigenetics. 2019 Oct 10;11(1):138. doi: 10.1186/s13148-019-0725-y.
504 Low doses of cisplatin induce gene alterations, cell cycle arrest, and apoptosis in human promyelocytic leukemia cells. Biomark Insights. 2016 Aug 24;11:113-21.
505 Effect of prenatal arsenic exposure on DNA methylation and leukocyte subpopulations in cord blood. Epigenetics. 2014 May;9(5):774-82. doi: 10.4161/epi.28153. Epub 2014 Feb 13.
506 Low Autophagy (ATG) Gene Expression Is Associated with an Immature AML Blast Cell Phenotype and Can Be Restored during AML Differentiation Therapy. Oxid Med Cell Longev. 2018 Mar 18;2018:1482795. doi: 10.1155/2018/1482795. eCollection 2018.
507 Inhibitory effect of PXR on ammonia-induced hepatocyte autophagy via P53. Toxicol Lett. 2018 Oct 1;295:153-161. doi: 10.1016/j.toxlet.2018.06.1066. Epub 2018 Jun 14.
508 Arsenic trioxide induces autophagic cell death in osteosarcoma cells via the ROS-TFEB signaling pathway. Biochem Biophys Res Commun. 2018 Jan 29;496(1):167-175. doi: 10.1016/j.bbrc.2018.01.018. Epub 2018 Jan 4.
509 TNF enhances trovafloxacin-induced in vitro hepatotoxicity by inhibiting protective autophagy. Toxicol Lett. 2021 May 15;342:73-84. doi: 10.1016/j.toxlet.2021.02.009. Epub 2021 Feb 17.
510 Dihydroceramide accumulation mediates cytotoxic autophagy of cancer cells via autolysosome destabilization. Autophagy. 2016 Nov;12(11):2213-2229. doi: 10.1080/15548627.2016.1213927. Epub 2016 Sep 16.
511 Induction of cysteine string protein after chronic antidepressant treatment in rat frontal cortex. Neurosci Lett. 2001 Apr 6;301(3):183-6. doi: 10.1016/s0304-3940(01)01638-x.
512 Exome-wide mutation profile in benzo[a]pyrene-derived post-stasis and immortal human mammary epithelial cells. Mutat Res Genet Toxicol Environ Mutagen. 2014 Dec;775-776:48-54. doi: 10.1016/j.mrgentox.2014.10.011. Epub 2014 Nov 4.
513 Quantitative phosphoproteomics reveal cellular responses from caffeine, coumarin and quercetin in treated HepG2 cells. Toxicol Appl Pharmacol. 2022 Aug 15;449:116110. doi: 10.1016/j.taap.2022.116110. Epub 2022 Jun 7.
514 Effect of quercetin on apoptosis of PANC-1 cells. J Korean Surg Soc. 2013 Dec;85(6):249-60. doi: 10.4174/jkss.2013.85.6.249. Epub 2013 Nov 26.
515 Identification of novel gene targets and putative regulators of arsenic-associated DNA methylation in human urothelial cells and bladder cancer. Chem Res Toxicol. 2015 Jun 15;28(6):1144-55. doi: 10.1021/tx500393y. Epub 2015 Jun 3.
516 Predictive toxicology using systemic biology and liver microfluidic "on chip" approaches: application to acetaminophen injury. Toxicol Appl Pharmacol. 2012 Mar 15;259(3):270-80.
517 Inhibition of BRD4 attenuates tumor cell self-renewal and suppresses stem cell signaling in MYC driven medulloblastoma. Oncotarget. 2014 May 15;5(9):2355-71.
518 Transcriptome-based functional classifiers for direct immunotoxicity. Arch Toxicol. 2014 Mar;88(3):673-89.
519 Serotonin transporter mRNA expression in peripheral leukocytes of patients with major depression before and after treatment with paroxetine. Neurosci Lett. 2005 Nov 25;389(1):12-6. doi: 10.1016/j.neulet.2005.06.048.
520 Age-dependent antidepressant pharmacogenomics: polymorphisms of the serotonin transporter and G protein beta3 subunit as predictors of response to fluoxetine and nortriptyline. Int J Neuropsychopharmacol. 2003 Dec;6(4):339-46. doi: 10.1017/S1461145703003663.
521 Serotonin transporter mRNA expression is decreased by lamivudine and ribavirin and increased by interferon in immune cells. Scand J Immunol. 2006 Feb;63(2):106-15. doi: 10.1111/j.1365-3083.2005.01715.x.
522 Cholesterol-lowering therapy evokes time-limited changes in serotonergic transmission. Psychiatry Res. 2005 Feb 28;133(2-3):197-203. doi: 10.1016/j.psychres.2004.11.005.
523 Design and synthesis of novel arylpiperazine derivatives containing the imidazole core targeting 5-HT(2A) receptor and 5-HT transporter. J Med Chem. 2011 Sep 22;54(18):6305-18. doi: 10.1021/jm200682b. Epub 2011 Aug 23.